<!DOCTYPE HTML PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/1999/REC-html401-19991224/loose.dtd">
<html><head><title>Report for Control 1717456977994 [GSEA]</title><link href='xtools.css' rel='stylesheet'><link href='https://www.gsea-msigdb.org/gsea/images/icon_16x16.png' rel='shortcut icon'></head><body><div class='richTable'><table cols='11' border='1'><th class='richTable'></th><th class='richTable'>GS<br> follow link to MSigDB</th><th class='richTable'>GS DETAILS</th><th class='richTable'>SIZE</th><th class='richTable'>ES</th><th class='richTable'>NES</th><th class='richTable'>NOM p-val</th><th class='richTable'>FDR q-val</th><th class='richTable'>FWER p-val</th><th class='richTable'>RANK AT MAX</th><th class='richTable'>LEADING EDGE</th><tr><td class='lessen'>1</td><td><a href='https://www.gsea-msigdb.org/gsea/msigdb/human/geneset/NIKOLSKY_BREAST_CANCER_19Q13.1_AMPLICON'>NIKOLSKY_BREAST_CANCER_19Q13.1_AMPLICON</a></td><td><a href='NIKOLSKY_BREAST_CANCER_19Q13.1_AMPLICON.html'>Details ...</a></td><td>22</td><td>-0.79</td><td>-2.04</td><td>0.000</td><td>0.092</td><td>0.118</td><td>2844</td><td>tags=68%, list=10%, signal=76%</td></tr><tr><td class='lessen'>2</td><td><a href='https://www.gsea-msigdb.org/gsea/msigdb/human/geneset/MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_DN'>MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_DN</a></td><td><a href='MANNE_COVID19_ICU_VS_HEALTHY_DONOR_PLATELETS_DN.html'>Details ...</a></td><td>159</td><td>-0.58</td><td>-1.85</td><td>0.040</td><td>0.381</td><td>0.563</td><td>4955</td><td>tags=52%, list=17%, signal=63%</td></tr><tr><td class='lessen'>3</td><td><a href='https://www.gsea-msigdb.org/gsea/msigdb/human/geneset/LOPES_METHYLATED_IN_COLON_CANCER_DN'>LOPES_METHYLATED_IN_COLON_CANCER_DN</a></td><td><a href='LOPES_METHYLATED_IN_COLON_CANCER_DN.html'>Details ...</a></td><td>27</td><td>-0.52</td><td>-1.77</td><td>0.008</td><td>0.601</td><td>0.805</td><td>3062</td><td>tags=37%, list=11%, signal=41%</td></tr><tr><td class='lessen'>4</td><td><a href='https://www.gsea-msigdb.org/gsea/msigdb/human/geneset/MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_DN'>MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_DN</a></td><td><a href='MANNE_COVID19_COMBINED_COHORT_VS_HEALTHY_DONOR_PLATELETS_DN.html'>Details ...</a></td><td>224</td><td>-0.51</td><td>-1.76</td><td>0.050</td><td>0.515</td><td>0.836</td><td>5432</td><td>tags=49%, list=19%, signal=60%</td></tr><tr><td class='lessen'>5</td><td><a href='https://www.gsea-msigdb.org/gsea/msigdb/human/geneset/ALONSO_METASTASIS_DN'>ALONSO_METASTASIS_DN</a></td><td><a href='ALONSO_METASTASIS_DN.html'>Details ...</a></td><td>25</td><td>-0.52</td><td>-1.75</td><td>0.006</td><td>0.426</td><td>0.843</td><td>4660</td><td>tags=36%, list=16%, signal=43%</td></tr><tr><td class='lessen'>6</td><td><a href='https://www.gsea-msigdb.org/gsea/msigdb/human/geneset/GENTILE_UV_RESPONSE_CLUSTER_D6'>GENTILE_UV_RESPONSE_CLUSTER_D6</a></td><td><a href='GENTILE_UV_RESPONSE_CLUSTER_D6.html'>Details ...</a></td><td>34</td><td>-0.45</td><td>-1.75</td><td>0.000</td><td>0.366</td><td>0.846</td><td>4521</td><td>tags=41%, list=16%, signal=49%</td></tr><tr><td class='lessen'>7</td><td><a href='https://www.gsea-msigdb.org/gsea/msigdb/human/geneset/BROWNE_HCMV_INFECTION_10HR_DN'>BROWNE_HCMV_INFECTION_10HR_DN</a></td><td><a href='BROWNE_HCMV_INFECTION_10HR_DN.html'>Details ...</a></td><td>56</td><td>-0.40</td><td>-1.75</td><td>0.006</td><td>0.314</td><td>0.846</td><td>2931</td><td>tags=30%, list=10%, signal=34%</td></tr><tr><td class='lessen'>8</td><td><a href='https://www.gsea-msigdb.org/gsea/msigdb/human/geneset/PYEON_HPV_POSITIVE_TUMORS_UP'>PYEON_HPV_POSITIVE_TUMORS_UP</a></td><td><a href='PYEON_HPV_POSITIVE_TUMORS_UP.html'>Details ...</a></td><td>97</td><td>-0.42</td><td>-1.71</td><td>0.002</td><td>0.393</td><td>0.912</td><td>3851</td><td>tags=29%, list=14%, signal=33%</td></tr><tr><td class='lessen'>9</td><td><a href='https://www.gsea-msigdb.org/gsea/msigdb/human/geneset/MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_DN'>MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_DN</a></td><td><a href='MANNE_COVID19_NONICU_VS_HEALTHY_DONOR_PLATELETS_DN.html'>Details ...</a></td><td>207</td><td>-0.53</td><td>-1.70</td><td>0.061</td><td>0.396</td><td>0.930</td><td>5432</td><td>tags=49%, list=19%, signal=60%</td></tr><tr><td class='lessen'>10</td><td><a href='https://www.gsea-msigdb.org/gsea/msigdb/human/geneset/FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP'>FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP</a></td><td><a href='FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP.html'>Details ...</a></td><td>34</td><td>-0.48</td><td>-1.68</td><td>0.022</td><td>0.421</td><td>0.948</td><td>4728</td><td>tags=29%, list=17%, signal=35%</td></tr><tr><td class='lessen'>11</td><td><a href='https://www.gsea-msigdb.org/gsea/msigdb/human/geneset/SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN'>SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN</a></td><td><a href='SILIGAN_TARGETS_OF_EWS_FLI1_FUSION_DN.html'>Details ...</a></td><td>17</td><td>-0.52</td><td>-1.66</td><td>0.020</td><td>0.440</td><td>0.962</td><td>7583</td><td>tags=53%, list=27%, signal=72%</td></tr><tr><td class='lessen'>12</td><td><a href='https://www.gsea-msigdb.org/gsea/msigdb/human/geneset/ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN'>ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN</a></td><td><a href='ZHONG_RESPONSE_TO_AZACITIDINE_AND_TSA_DN.html'>Details ...</a></td><td>68</td><td>-0.38</td><td>-1.65</td><td>0.006</td><td>0.446</td><td>0.973</td><td>5710</td><td>tags=28%, list=20%, signal=35%</td></tr><tr><td class='lessen'>13</td><td><a href='https://www.gsea-msigdb.org/gsea/msigdb/human/geneset/ZHANG_BREAST_CANCER_PROGENITORS_UP'>ZHANG_BREAST_CANCER_PROGENITORS_UP</a></td><td><a href='ZHANG_BREAST_CANCER_PROGENITORS_UP.html'>Details ...</a></td><td>426</td><td>-0.34</td><td>-1.64</td><td>0.027</td><td>0.439</td><td>0.974</td><td>8009</td><td>tags=38%, list=28%, signal=52%</td></tr><tr><td class='lessen'>14</td><td><a href='https://www.gsea-msigdb.org/gsea/msigdb/human/geneset/LIU_COMMON_CANCER_GENES'>LIU_COMMON_CANCER_GENES</a></td><td><a href='LIU_COMMON_CANCER_GENES.html'>Details ...</a></td><td>60</td><td>-0.38</td><td>-1.61</td><td>0.014</td><td>0.532</td><td>0.987</td><td>3137</td><td>tags=20%, list=11%, signal=22%</td></tr><tr><td class='lessen'>15</td><td><a href='https://www.gsea-msigdb.org/gsea/msigdb/human/geneset/SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_PRE_TREATMENT_UP'>SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_PRE_TREATMENT_UP</a></td><td><a href='SALVADOR_MARTIN_PEDIATRIC_TBD_ANTI_TNF_THERAPY_NONRESPONDER_PRE_TREATMENT_UP.html'>Details ...</a></td><td>29</td><td>-0.54</td><td>-1.60</td><td>0.039</td><td>0.526</td><td>0.992</td><td>570</td><td>tags=28%, list=2%, signal=28%</td></tr><tr><td class='lessen'>16</td><td><a href='https://www.gsea-msigdb.org/gsea/msigdb/human/geneset/SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B'>SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B</a></td><td><a href='SUZUKI_RESPONSE_TO_TSA_AND_DECITABINE_1B.html'>Details ...</a></td><td>15</td><td>-0.50</td><td>-1.59</td><td>0.021</td><td>0.513</td><td>0.994</td><td>2950</td><td>tags=33%, list=10%, signal=37%</td></tr><tr><td class='lessen'>17</td><td><a href='https://www.gsea-msigdb.org/gsea/msigdb/human/geneset/HUTTMANN_B_CLL_POOR_SURVIVAL_DN'>HUTTMANN_B_CLL_POOR_SURVIVAL_DN</a></td><td><a href='HUTTMANN_B_CLL_POOR_SURVIVAL_DN.html'>Details ...</a></td><td>59</td><td>-0.40</td><td>-1.57</td><td>0.028</td><td>0.558</td><td>0.995</td><td>5745</td><td>tags=42%, list=20%, signal=53%</td></tr><tr><td class='lessen'>18</td><td><a href='https://www.gsea-msigdb.org/gsea/msigdb/human/geneset/ZHAN_MULTIPLE_MYELOMA_MF_DN'>ZHAN_MULTIPLE_MYELOMA_MF_DN</a></td><td><a href='ZHAN_MULTIPLE_MYELOMA_MF_DN.html'>Details ...</a></td><td>43</td><td>-0.41</td><td>-1.57</td><td>0.021</td><td>0.532</td><td>0.996</td><td>5747</td><td>tags=33%, list=20%, signal=41%</td></tr><tr><td class='lessen'>19</td><td><a href='https://www.gsea-msigdb.org/gsea/msigdb/human/geneset/MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED'>MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED</a></td><td><a href='MIKKELSEN_ES_HCP_WITH_H3_UNMETHYLATED.html'>Details ...</a></td><td>50</td><td>-0.39</td><td>-1.55</td><td>0.016</td><td>0.603</td><td>0.999</td><td>6702</td><td>tags=42%, list=24%, signal=55%</td></tr><tr><td class='lessen'>20</td><td><a href='https://www.gsea-msigdb.org/gsea/msigdb/human/geneset/RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN'>RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN</a></td><td><a href='RICKMAN_TUMOR_DIFFERENTIATED_MODERATELY_VS_POORLY_DN.html'>Details ...</a></td><td>16</td><td>-0.57</td><td>-1.54</td><td>0.042</td><td>0.587</td><td>0.999</td><td>6085</td><td>tags=50%, list=21%, signal=64%</td></tr><tr><td class='lessen'>21</td><td>SHIPP_DLBCL_VS_FOLLICULAR_LYMPHOMA_DN</td><td></td><td>44</td><td>-0.40</td><td>-1.53</td><td>0.080</td><td>0.612</td><td>0.999</td><td>5962</td><td>tags=34%, list=21%, signal=43%</td></tr><tr><td class='lessen'>22</td><td>TSENG_ADIPOGENIC_POTENTIAL_UP</td><td></td><td>29</td><td>-0.39</td><td>-1.53</td><td>0.026</td><td>0.609</td><td>1.000</td><td>3543</td><td>tags=24%, list=12%, signal=28%</td></tr><tr><td class='lessen'>23</td><td>GAZIN_EPIGENETIC_SILENCING_BY_KRAS</td><td></td><td>24</td><td>-0.46</td><td>-1.53</td><td>0.056</td><td>0.583</td><td>1.000</td><td>4788</td><td>tags=42%, list=17%, signal=50%</td></tr><tr><td class='lessen'>24</td><td>ACEVEDO_LIVER_CANCER_WITH_H3K27ME3_DN</td><td></td><td>185</td><td>-0.31</td><td>-1.52</td><td>0.006</td><td>0.561</td><td>1.000</td><td>4427</td><td>tags=28%, list=16%, signal=33%</td></tr><tr><td class='lessen'>25</td><td>WHITFIELD_CELL_CYCLE_G1_S</td><td></td><td>130</td><td>-0.32</td><td>-1.52</td><td>0.019</td><td>0.575</td><td>1.000</td><td>6159</td><td>tags=31%, list=22%, signal=39%</td></tr><tr><td class='lessen'>26</td><td>NAGASHIMA_NRG1_SIGNALING_DN</td><td></td><td>51</td><td>-0.36</td><td>-1.51</td><td>0.032</td><td>0.556</td><td>1.000</td><td>6743</td><td>tags=47%, list=24%, signal=62%</td></tr><tr><td class='lessen'>27</td><td>NEWMAN_ERCC6_TARGETS_DN</td><td></td><td>31</td><td>-0.44</td><td>-1.51</td><td>0.041</td><td>0.563</td><td>1.000</td><td>8127</td><td>tags=48%, list=29%, signal=68%</td></tr><tr><td class='lessen'>28</td><td>GENTILE_UV_RESPONSE_CLUSTER_D4</td><td></td><td>54</td><td>-0.38</td><td>-1.49</td><td>0.059</td><td>0.597</td><td>1.000</td><td>5644</td><td>tags=35%, list=20%, signal=44%</td></tr><tr><td class='lessen'>29</td><td>OUILLETTE_CLL_13Q14_DELETION_UP</td><td></td><td>71</td><td>-0.34</td><td>-1.48</td><td>0.056</td><td>0.641</td><td>1.000</td><td>4343</td><td>tags=25%, list=15%, signal=30%</td></tr><tr><td class='lessen'>30</td><td>NIKOLSKY_BREAST_CANCER_5P15_AMPLICON</td><td></td><td>21</td><td>-0.46</td><td>-1.46</td><td>0.084</td><td>0.673</td><td>1.000</td><td>2485</td><td>tags=24%, list=9%, signal=26%</td></tr><tr><td class='lessen'>31</td><td>KYNG_NORMAL_AGING_UP</td><td></td><td>15</td><td>-0.51</td><td>-1.46</td><td>0.085</td><td>0.661</td><td>1.000</td><td>1123</td><td>tags=27%, list=4%, signal=28%</td></tr><tr><td class='lessen'>32</td><td>RIZ_ERYTHROID_DIFFERENTIATION_APOBEC2</td><td></td><td>21</td><td>-0.46</td><td>-1.46</td><td>0.070</td><td>0.647</td><td>1.000</td><td>7902</td><td>tags=57%, list=28%, signal=79%</td></tr><tr><td class='lessen'>33</td><td>PIEPOLI_LGI1_TARGETS_DN</td><td></td><td>15</td><td>-0.49</td><td>-1.45</td><td>0.073</td><td>0.663</td><td>1.000</td><td>8869</td><td>tags=67%, list=31%, signal=97%</td></tr><tr><td class='lessen'>34</td><td>THUM_SYSTOLIC_HEART_FAILURE_DN</td><td></td><td>216</td><td>-0.31</td><td>-1.45</td><td>0.055</td><td>0.652</td><td>1.000</td><td>4196</td><td>tags=24%, list=15%, signal=28%</td></tr><tr><td class='lessen'>35</td><td>GEORGES_CELL_CYCLE_MIR192_TARGETS</td><td></td><td>62</td><td>-0.36</td><td>-1.45</td><td>0.071</td><td>0.635</td><td>1.000</td><td>4918</td><td>tags=32%, list=17%, signal=39%</td></tr><tr><td class='lessen'>36</td><td>RIZ_ERYTHROID_DIFFERENTIATION_6HR</td><td></td><td>30</td><td>-0.39</td><td>-1.44</td><td>0.070</td><td>0.634</td><td>1.000</td><td>5864</td><td>tags=43%, list=21%, signal=55%</td></tr><tr><td class='lessen'>37</td><td>YEGNASUBRAMANIAN_PROSTATE_CANCER</td><td></td><td>111</td><td>-0.30</td><td>-1.44</td><td>0.017</td><td>0.646</td><td>1.000</td><td>4801</td><td>tags=26%, list=17%, signal=31%</td></tr><tr><td class='lessen'>38</td><td>RORIE_TARGETS_OF_EWSR1_FLI1_FUSION_DN</td><td></td><td>25</td><td>-0.47</td><td>-1.44</td><td>0.090</td><td>0.634</td><td>1.000</td><td>7701</td><td>tags=56%, list=27%, signal=77%</td></tr><tr><td class='lessen'>39</td><td>PUJANA_BREAST_CANCER_WITH_BRCA1_MUTATED_UP</td><td></td><td>55</td><td>-0.36</td><td>-1.43</td><td>0.096</td><td>0.647</td><td>1.000</td><td>5948</td><td>tags=35%, list=21%, signal=44%</td></tr><tr><td class='lessen'>40</td><td>NUMATA_CSF3_SIGNALING_VIA_STAT3</td><td></td><td>21</td><td>-0.40</td><td>-1.43</td><td>0.068</td><td>0.637</td><td>1.000</td><td>2005</td><td>tags=29%, list=7%, signal=31%</td></tr><tr><td class='lessen'>41</td><td>ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_DN</td><td></td><td>103</td><td>-0.33</td><td>-1.41</td><td>0.049</td><td>0.667</td><td>1.000</td><td>4274</td><td>tags=25%, list=15%, signal=30%</td></tr><tr><td class='lessen'>42</td><td>COWLING_MYCN_TARGETS</td><td></td><td>41</td><td>-0.35</td><td>-1.41</td><td>0.041</td><td>0.665</td><td>1.000</td><td>5290</td><td>tags=29%, list=19%, signal=36%</td></tr><tr><td class='lessen'>43</td><td>GRADE_COLON_VS_RECTAL_CANCER_DN</td><td></td><td>53</td><td>-0.32</td><td>-1.40</td><td>0.060</td><td>0.683</td><td>1.000</td><td>5666</td><td>tags=38%, list=20%, signal=47%</td></tr><tr><td class='lessen'>44</td><td>LEIN_LOCALIZED_TO_DISTAL_AND_PROXIMAL_DENDRITES</td><td></td><td>17</td><td>-0.46</td><td>-1.40</td><td>0.106</td><td>0.678</td><td>1.000</td><td>6989</td><td>tags=47%, list=25%, signal=62%</td></tr><tr><td class='lessen'>45</td><td>KANG_AR_TARGETS_UP</td><td></td><td>15</td><td>-0.46</td><td>-1.40</td><td>0.106</td><td>0.677</td><td>1.000</td><td>5643</td><td>tags=33%, list=20%, signal=42%</td></tr><tr><td class='lessen'>46</td><td>DAZARD_RESPONSE_TO_UV_NHEK_DN</td><td></td><td>295</td><td>-0.31</td><td>-1.39</td><td>0.105</td><td>0.696</td><td>1.000</td><td>5845</td><td>tags=30%, list=21%, signal=38%</td></tr><tr><td class='lessen'>47</td><td>HUMMEL_BURKITTS_LYMPHOMA_UP</td><td></td><td>43</td><td>-0.33</td><td>-1.39</td><td>0.042</td><td>0.688</td><td>1.000</td><td>5081</td><td>tags=35%, list=18%, signal=42%</td></tr><tr><td class='lessen'>48</td><td>MEISSNER_NPC_HCP_WITH_H3K4ME2_AND_H3K27ME3</td><td></td><td>272</td><td>-0.29</td><td>-1.38</td><td>0.025</td><td>0.703</td><td>1.000</td><td>5779</td><td>tags=31%, list=20%, signal=38%</td></tr><tr><td class='lessen'>49</td><td>GAJATE_RESPONSE_TO_TRABECTEDIN_DN</td><td></td><td>20</td><td>-0.39</td><td>-1.37</td><td>0.124</td><td>0.720</td><td>1.000</td><td>6221</td><td>tags=40%, list=22%, signal=51%</td></tr><tr><td class='lessen'>50</td><td>DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN</td><td></td><td>83</td><td>-0.34</td><td>-1.37</td><td>0.120</td><td>0.717</td><td>1.000</td><td>8066</td><td>tags=46%, list=28%, signal=64%</td></tr><tr><td class='lessen'>51</td><td>GOUYER_TATI_TARGETS_DN</td><td></td><td>16</td><td>-0.50</td><td>-1.37</td><td>0.112</td><td>0.712</td><td>1.000</td><td>1932</td><td>tags=31%, list=7%, signal=34%</td></tr><tr><td class='lessen'>52</td><td>YUAN_ZNF143_PARTNERS</td><td></td><td>21</td><td>-0.40</td><td>-1.36</td><td>0.132</td><td>0.722</td><td>1.000</td><td>3713</td><td>tags=33%, list=13%, signal=38%</td></tr><tr><td class='lessen'>53</td><td>YANG_BREAST_CANCER_ESR1_DN</td><td></td><td>24</td><td>-0.42</td><td>-1.35</td><td>0.104</td><td>0.733</td><td>1.000</td><td>6174</td><td>tags=42%, list=22%, signal=53%</td></tr><tr><td class='lessen'>54</td><td>PUJANA_XPRSS_INT_NETWORK</td><td></td><td>168</td><td>-0.29</td><td>-1.35</td><td>0.133</td><td>0.721</td><td>1.000</td><td>8136</td><td>tags=36%, list=29%, signal=51%</td></tr><tr><td class='lessen'>55</td><td>WALLACE_PROSTATE_CANCER_RACE_DN</td><td></td><td>84</td><td>-0.31</td><td>-1.34</td><td>0.087</td><td>0.751</td><td>1.000</td><td>6947</td><td>tags=38%, list=24%, signal=50%</td></tr><tr><td class='lessen'>56</td><td>BURTON_ADIPOGENESIS_11</td><td></td><td>50</td><td>-0.34</td><td>-1.33</td><td>0.118</td><td>0.783</td><td>1.000</td><td>3906</td><td>tags=26%, list=14%, signal=30%</td></tr><tr><td class='lessen'>57</td><td>HADDAD_B_LYMPHOCYTE_PROGENITOR</td><td></td><td>280</td><td>-0.28</td><td>-1.32</td><td>0.165</td><td>0.791</td><td>1.000</td><td>7591</td><td>tags=38%, list=27%, signal=51%</td></tr><tr><td class='lessen'>58</td><td>MIKKELSEN_IPS_HCP_WITH_H3_UNMETHYLATED</td><td></td><td>65</td><td>-0.31</td><td>-1.32</td><td>0.113</td><td>0.782</td><td>1.000</td><td>7793</td><td>tags=40%, list=27%, signal=55%</td></tr><tr><td class='lessen'>59</td><td>PLASARI_TGFB1_SIGNALING_VIA_NFIC_1HR_DN</td><td></td><td>103</td><td>-0.27</td><td>-1.32</td><td>0.071</td><td>0.769</td><td>1.000</td><td>6382</td><td>tags=30%, list=22%, signal=39%</td></tr><tr><td class='lessen'>60</td><td>GENTILE_UV_RESPONSE_CLUSTER_D2</td><td></td><td>36</td><td>-0.36</td><td>-1.32</td><td>0.176</td><td>0.761</td><td>1.000</td><td>5166</td><td>tags=31%, list=18%, signal=37%</td></tr><tr><td class='lessen'>61</td><td>VERHAAK_GLIOBLASTOMA_PRONEURAL</td><td></td><td>168</td><td>-0.27</td><td>-1.31</td><td>0.054</td><td>0.784</td><td>1.000</td><td>6007</td><td>tags=31%, list=21%, signal=39%</td></tr><tr><td class='lessen'>62</td><td>HASLINGER_B_CLL_WITH_MUTATED_VH_GENES</td><td></td><td>18</td><td>-0.43</td><td>-1.31</td><td>0.176</td><td>0.776</td><td>1.000</td><td>4418</td><td>tags=28%, list=16%, signal=33%</td></tr><tr><td class='lessen'>63</td><td>KAUFFMANN_DNA_REPAIR_GENES</td><td></td><td>228</td><td>-0.25</td><td>-1.31</td><td>0.110</td><td>0.780</td><td>1.000</td><td>8143</td><td>tags=33%, list=29%, signal=46%</td></tr><tr><td class='lessen'>64</td><td>MORI_PLASMA_CELL_DN</td><td></td><td>36</td><td>-0.33</td><td>-1.30</td><td>0.150</td><td>0.781</td><td>1.000</td><td>6274</td><td>tags=42%, list=22%, signal=53%</td></tr><tr><td class='lessen'>65</td><td>BOGNI_TREATMENT_RELATED_MYELOID_LEUKEMIA_DN</td><td></td><td>32</td><td>-0.33</td><td>-1.30</td><td>0.154</td><td>0.777</td><td>1.000</td><td>11560</td><td>tags=53%, list=41%, signal=90%</td></tr><tr><td class='lessen'>66</td><td>IVANOVA_HEMATOPOIESIS_STEM_CELL_LONG_TERM</td><td></td><td>199</td><td>-0.25</td><td>-1.30</td><td>0.046</td><td>0.768</td><td>1.000</td><td>3612</td><td>tags=20%, list=13%, signal=22%</td></tr><tr><td class='lessen'>67</td><td>NABA_BASEMENT_MEMBRANES</td><td></td><td>40</td><td>-0.35</td><td>-1.29</td><td>0.148</td><td>0.785</td><td>1.000</td><td>5995</td><td>tags=33%, list=21%, signal=41%</td></tr><tr><td class='lessen'>68</td><td>EPPERT_LSC_R</td><td></td><td>42</td><td>-0.31</td><td>-1.29</td><td>0.115</td><td>0.780</td><td>1.000</td><td>7440</td><td>tags=38%, list=26%, signal=52%</td></tr><tr><td class='lessen'>69</td><td>KYNG_WERNER_SYNDROM_DN</td><td></td><td>19</td><td>-0.40</td><td>-1.28</td><td>0.190</td><td>0.830</td><td>1.000</td><td>4121</td><td>tags=26%, list=15%, signal=31%</td></tr><tr><td class='lessen'>70</td><td>DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN</td><td></td><td>85</td><td>-0.31</td><td>-1.28</td><td>0.227</td><td>0.824</td><td>1.000</td><td>8066</td><td>tags=40%, list=28%, signal=56%</td></tr><tr><td class='lessen'>71</td><td>HEIDENBLAD_AMPLIFIED_IN_PANCREATIC_CANCER</td><td></td><td>56</td><td>-0.29</td><td>-1.27</td><td>0.110</td><td>0.838</td><td>1.000</td><td>3594</td><td>tags=18%, list=13%, signal=20%</td></tr><tr><td class='lessen'>72</td><td>MEISSNER_NPC_HCP_WITH_H3K27ME3</td><td></td><td>52</td><td>-0.32</td><td>-1.27</td><td>0.108</td><td>0.832</td><td>1.000</td><td>8907</td><td>tags=48%, list=31%, signal=70%</td></tr><tr><td class='lessen'>73</td><td>NIKOLSKY_BREAST_CANCER_7Q21_Q22_AMPLICON</td><td></td><td>70</td><td>-0.29</td><td>-1.27</td><td>0.130</td><td>0.830</td><td>1.000</td><td>4553</td><td>tags=27%, list=16%, signal=32%</td></tr><tr><td class='lessen'>74</td><td>SLEBOS_HEAD_AND_NECK_CANCER_WITH_HPV_UP</td><td></td><td>74</td><td>-0.30</td><td>-1.27</td><td>0.141</td><td>0.822</td><td>1.000</td><td>11108</td><td>tags=49%, list=39%, signal=80%</td></tr><tr><td class='lessen'>75</td><td>BROWNE_HCMV_INFECTION_6HR_DN</td><td></td><td>157</td><td>-0.25</td><td>-1.26</td><td>0.131</td><td>0.812</td><td>1.000</td><td>7972</td><td>tags=39%, list=28%, signal=54%</td></tr><tr><td class='lessen'>76</td><td>GRABARCZYK_BCL11B_TARGETS_DN</td><td></td><td>60</td><td>-0.30</td><td>-1.26</td><td>0.168</td><td>0.808</td><td>1.000</td><td>5683</td><td>tags=30%, list=20%, signal=37%</td></tr><tr><td class='lessen'>77</td><td>MIKKELSEN_MCV6_ICP_WITH_H3K27ME3</td><td></td><td>59</td><td>-0.35</td><td>-1.26</td><td>0.144</td><td>0.805</td><td>1.000</td><td>7864</td><td>tags=46%, list=28%, signal=63%</td></tr><tr><td class='lessen'>78</td><td>CHEOK_RESPONSE_TO_MERCAPTOPURINE_AND_HD_MTX_DN</td><td></td><td>25</td><td>-0.32</td><td>-1.26</td><td>0.176</td><td>0.814</td><td>1.000</td><td>7780</td><td>tags=36%, list=27%, signal=50%</td></tr><tr><td class='lessen'>79</td><td>IVANOVA_HEMATOPOIESIS_STEM_CELL_SHORT_TERM</td><td></td><td>21</td><td>-0.40</td><td>-1.26</td><td>0.196</td><td>0.805</td><td>1.000</td><td>7438</td><td>tags=48%, list=26%, signal=64%</td></tr><tr><td class='lessen'>80</td><td>ZHAN_MULTIPLE_MYELOMA_PR_DN</td><td></td><td>49</td><td>-0.30</td><td>-1.25</td><td>0.193</td><td>0.802</td><td>1.000</td><td>5845</td><td>tags=31%, list=21%, signal=38%</td></tr><tr><td class='lessen'>81</td><td>MARTINEZ_RESPONSE_TO_TRABECTEDIN_DN</td><td></td><td>267</td><td>-0.24</td><td>-1.25</td><td>0.170</td><td>0.814</td><td>1.000</td><td>5030</td><td>tags=22%, list=18%, signal=26%</td></tr><tr><td class='lessen'>82</td><td>GAUSSMANN_MLL_AF4_FUSION_TARGETS_C_DN</td><td></td><td>22</td><td>-0.38</td><td>-1.24</td><td>0.225</td><td>0.820</td><td>1.000</td><td>6094</td><td>tags=41%, list=21%, signal=52%</td></tr><tr><td class='lessen'>83</td><td>IKEDA_MIR30_TARGETS_DN</td><td></td><td>24</td><td>-0.40</td><td>-1.24</td><td>0.237</td><td>0.811</td><td>1.000</td><td>1923</td><td>tags=17%, list=7%, signal=18%</td></tr><tr><td class='lessen'>84</td><td>ZWANG_DOWN_BY_2ND_EGF_PULSE</td><td></td><td>295</td><td>-0.27</td><td>-1.24</td><td>0.177</td><td>0.802</td><td>1.000</td><td>5650</td><td>tags=28%, list=20%, signal=35%</td></tr><tr><td class='lessen'>85</td><td>GOLUB_ALL_VS_AML_UP</td><td></td><td>24</td><td>-0.36</td><td>-1.24</td><td>0.216</td><td>0.793</td><td>1.000</td><td>7210</td><td>tags=38%, list=25%, signal=50%</td></tr><tr><td class='lessen'>86</td><td>TURASHVILI_BREAST_CARCINOMA_DUCTAL_VS_LOBULAR_UP</td><td></td><td>24</td><td>-0.39</td><td>-1.24</td><td>0.200</td><td>0.797</td><td>1.000</td><td>2879</td><td>tags=25%, list=10%, signal=28%</td></tr><tr><td class='lessen'>87</td><td>IVANOVA_HEMATOPOIESIS_STEM_CELL</td><td></td><td>181</td><td>-0.25</td><td>-1.24</td><td>0.129</td><td>0.799</td><td>1.000</td><td>6364</td><td>tags=30%, list=22%, signal=39%</td></tr><tr><td class='lessen'>88</td><td>PUJANA_BRCA2_PCC_NETWORK</td><td></td><td>424</td><td>-0.23</td><td>-1.23</td><td>0.179</td><td>0.798</td><td>1.000</td><td>8192</td><td>tags=33%, list=29%, signal=45%</td></tr><tr><td class='lessen'>89</td><td>CHEN_ETV5_TARGETS_TESTIS</td><td></td><td>22</td><td>-0.39</td><td>-1.23</td><td>0.196</td><td>0.801</td><td>1.000</td><td>3572</td><td>tags=27%, list=13%, signal=31%</td></tr><tr><td class='lessen'>90</td><td>GENTILE_UV_HIGH_DOSE_DN</td><td></td><td>285</td><td>-0.23</td><td>-1.23</td><td>0.198</td><td>0.796</td><td>1.000</td><td>4946</td><td>tags=24%, list=17%, signal=29%</td></tr><tr><td class='lessen'>91</td><td>TAVAZOIE_METASTASIS</td><td></td><td>91</td><td>-0.28</td><td>-1.23</td><td>0.154</td><td>0.791</td><td>1.000</td><td>4553</td><td>tags=27%, list=16%, signal=33%</td></tr><tr><td class='lessen'>92</td><td>NOUZOVA_METHYLATED_IN_APL</td><td></td><td>54</td><td>-0.29</td><td>-1.23</td><td>0.155</td><td>0.786</td><td>1.000</td><td>3848</td><td>tags=24%, list=14%, signal=28%</td></tr><tr><td class='lessen'>93</td><td>HOELZEL_NF1_TARGETS_DN</td><td></td><td>112</td><td>-0.27</td><td>-1.23</td><td>0.129</td><td>0.786</td><td>1.000</td><td>7461</td><td>tags=38%, list=26%, signal=52%</td></tr><tr><td class='lessen'>94</td><td>THEODOROU_MAMMARY_TUMORIGENESIS</td><td></td><td>27</td><td>-0.33</td><td>-1.23</td><td>0.175</td><td>0.779</td><td>1.000</td><td>2700</td><td>tags=26%, list=10%, signal=29%</td></tr><tr><td class='lessen'>95</td><td>OSMAN_BLADDER_CANCER_DN</td><td></td><td>381</td><td>-0.23</td><td>-1.22</td><td>0.223</td><td>0.778</td><td>1.000</td><td>7976</td><td>tags=33%, list=28%, signal=45%</td></tr><tr><td class='lessen'>96</td><td>WENDT_COHESIN_TARGETS_UP</td><td></td><td>32</td><td>-0.43</td><td>-1.22</td><td>0.297</td><td>0.791</td><td>1.000</td><td>3055</td><td>tags=28%, list=11%, signal=31%</td></tr><tr><td class='lessen'>97</td><td>MIKKELSEN_NPC_HCP_WITH_H3K27ME3</td><td></td><td>251</td><td>-0.27</td><td>-1.22</td><td>0.118</td><td>0.791</td><td>1.000</td><td>5864</td><td>tags=29%, list=21%, signal=36%</td></tr><tr><td class='lessen'>98</td><td>BONOME_OVARIAN_CANCER_POOR_SURVIVAL_DN</td><td></td><td>22</td><td>-0.34</td><td>-1.21</td><td>0.228</td><td>0.790</td><td>1.000</td><td>6041</td><td>tags=36%, list=21%, signal=46%</td></tr><tr><td class='lessen'>99</td><td>DAZARD_UV_RESPONSE_CLUSTER_G6</td><td></td><td>144</td><td>-0.31</td><td>-1.21</td><td>0.266</td><td>0.784</td><td>1.000</td><td>5586</td><td>tags=31%, list=20%, signal=39%</td></tr><tr><td class='lessen'>100</td><td>ZHENG_FOXP3_TARGETS_UP</td><td></td><td>26</td><td>-0.33</td><td>-1.21</td><td>0.219</td><td>0.777</td><td>1.000</td><td>3302</td><td>tags=23%, list=12%, signal=26%</td></tr><tr><td class='lessen'>101</td><td>NIKOLSKY_BREAST_CANCER_8P12_P11_AMPLICON</td><td></td><td>49</td><td>-0.31</td><td>-1.21</td><td>0.213</td><td>0.774</td><td>1.000</td><td>5656</td><td>tags=33%, list=20%, signal=41%</td></tr><tr><td class='lessen'>102</td><td>RIZ_ERYTHROID_DIFFERENTIATION</td><td></td><td>80</td><td>-0.29</td><td>-1.21</td><td>0.228</td><td>0.767</td><td>1.000</td><td>4343</td><td>tags=21%, list=15%, signal=25%</td></tr><tr><td class='lessen'>103</td><td>MEISSNER_NPC_ICP_WITH_H3_UNMETHYLATED</td><td></td><td>16</td><td>-0.42</td><td>-1.21</td><td>0.245</td><td>0.765</td><td>1.000</td><td>10007</td><td>tags=56%, list=35%, signal=87%</td></tr><tr><td class='lessen'>104</td><td>RODWELL_AGING_KIDNEY_NO_BLOOD_DN</td><td></td><td>142</td><td>-0.26</td><td>-1.21</td><td>0.182</td><td>0.761</td><td>1.000</td><td>2071</td><td>tags=15%, list=7%, signal=17%</td></tr><tr><td class='lessen'>105</td><td>JAZAERI_BREAST_CANCER_BRCA1_VS_BRCA2_DN</td><td></td><td>40</td><td>-0.30</td><td>-1.21</td><td>0.234</td><td>0.765</td><td>1.000</td><td>8661</td><td>tags=38%, list=31%, signal=54%</td></tr><tr><td class='lessen'>106</td><td>PUJANA_BRCA_CENTERED_NETWORK</td><td></td><td>118</td><td>-0.26</td><td>-1.20</td><td>0.239</td><td>0.765</td><td>1.000</td><td>5081</td><td>tags=23%, list=18%, signal=28%</td></tr><tr><td class='lessen'>107</td><td>GENTILE_UV_LOW_DOSE_DN</td><td></td><td>64</td><td>-0.30</td><td>-1.20</td><td>0.227</td><td>0.759</td><td>1.000</td><td>8035</td><td>tags=41%, list=28%, signal=57%</td></tr><tr><td class='lessen'>108</td><td>WANG_CLIM2_TARGETS_UP</td><td></td><td>255</td><td>-0.22</td><td>-1.20</td><td>0.203</td><td>0.774</td><td>1.000</td><td>6159</td><td>tags=26%, list=22%, signal=33%</td></tr><tr><td class='lessen'>109</td><td>YAUCH_HEDGEHOG_SIGNALING_PARACRINE_DN</td><td></td><td>204</td><td>-0.23</td><td>-1.20</td><td>0.097</td><td>0.769</td><td>1.000</td><td>6824</td><td>tags=30%, list=24%, signal=40%</td></tr><tr><td class='lessen'>110</td><td>RODRIGUES_NTN1_TARGETS_UP</td><td></td><td>15</td><td>-0.42</td><td>-1.19</td><td>0.260</td><td>0.766</td><td>1.000</td><td>3419</td><td>tags=27%, list=12%, signal=30%</td></tr><tr><td class='lessen'>111</td><td>DING_LUNG_CANCER_EXPRESSION_BY_COPY_NUMBER</td><td></td><td>97</td><td>-0.29</td><td>-1.19</td><td>0.269</td><td>0.769</td><td>1.000</td><td>10351</td><td>tags=42%, list=36%, signal=66%</td></tr><tr><td class='lessen'>112</td><td>CLIMENT_BREAST_CANCER_COPY_NUMBER_UP</td><td></td><td>21</td><td>-0.34</td><td>-1.19</td><td>0.234</td><td>0.766</td><td>1.000</td><td>3640</td><td>tags=24%, list=13%, signal=27%</td></tr><tr><td class='lessen'>113</td><td>SMID_BREAST_CANCER_LUMINAL_B_UP</td><td></td><td>149</td><td>-0.24</td><td>-1.19</td><td>0.096</td><td>0.763</td><td>1.000</td><td>5891</td><td>tags=27%, list=21%, signal=34%</td></tr><tr><td class='lessen'>114</td><td>ODONNELL_METASTASIS_DN</td><td></td><td>21</td><td>-0.35</td><td>-1.19</td><td>0.251</td><td>0.764</td><td>1.000</td><td>6911</td><td>tags=29%, list=24%, signal=38%</td></tr><tr><td class='lessen'>115</td><td>DE_YY1_TARGETS_UP</td><td></td><td>18</td><td>-0.38</td><td>-1.19</td><td>0.241</td><td>0.762</td><td>1.000</td><td>5820</td><td>tags=39%, list=20%, signal=49%</td></tr><tr><td class='lessen'>116</td><td>ROVERSI_GLIOMA_LOH_REGIONS</td><td></td><td>39</td><td>-0.32</td><td>-1.18</td><td>0.244</td><td>0.764</td><td>1.000</td><td>6934</td><td>tags=33%, list=24%, signal=44%</td></tr><tr><td class='lessen'>117</td><td>STEIN_ESRRA_TARGETS_DN</td><td></td><td>102</td><td>-0.25</td><td>-1.18</td><td>0.205</td><td>0.772</td><td>1.000</td><td>7674</td><td>tags=35%, list=27%, signal=48%</td></tr><tr><td class='lessen'>118</td><td>NUTT_GBM_VS_AO_GLIOMA_DN</td><td></td><td>34</td><td>-0.31</td><td>-1.18</td><td>0.237</td><td>0.774</td><td>1.000</td><td>7890</td><td>tags=41%, list=28%, signal=57%</td></tr><tr><td class='lessen'>119</td><td>AUNG_GASTRIC_CANCER</td><td></td><td>47</td><td>-0.29</td><td>-1.17</td><td>0.220</td><td>0.770</td><td>1.000</td><td>4570</td><td>tags=26%, list=16%, signal=30%</td></tr><tr><td class='lessen'>120</td><td>HUI_MAPK14_TARGETS_UP</td><td></td><td>19</td><td>-0.36</td><td>-1.17</td><td>0.262</td><td>0.783</td><td>1.000</td><td>3896</td><td>tags=21%, list=14%, signal=24%</td></tr><tr><td class='lessen'>121</td><td>NIKOLSKY_BREAST_CANCER_8Q12_Q22_AMPLICON</td><td></td><td>121</td><td>-0.27</td><td>-1.17</td><td>0.225</td><td>0.784</td><td>1.000</td><td>6471</td><td>tags=31%, list=23%, signal=39%</td></tr><tr><td class='lessen'>122</td><td>KIM_MYCN_AMPLIFICATION_TARGETS_DN</td><td></td><td>104</td><td>-0.25</td><td>-1.16</td><td>0.219</td><td>0.787</td><td>1.000</td><td>5674</td><td>tags=28%, list=20%, signal=35%</td></tr><tr><td class='lessen'>123</td><td>OISHI_CHOLANGIOMA_STEM_CELL_LIKE_UP</td><td></td><td>334</td><td>-0.22</td><td>-1.16</td><td>0.304</td><td>0.793</td><td>1.000</td><td>7332</td><td>tags=29%, list=26%, signal=39%</td></tr><tr><td class='lessen'>124</td><td>BROWNE_HCMV_INFECTION_30MIN_DN</td><td></td><td>127</td><td>-0.24</td><td>-1.16</td><td>0.241</td><td>0.787</td><td>1.000</td><td>9065</td><td>tags=43%, list=32%, signal=63%</td></tr><tr><td class='lessen'>125</td><td>STAMBOLSKY_RESPONSE_TO_VITAMIN_D3_DN</td><td></td><td>24</td><td>-0.33</td><td>-1.16</td><td>0.230</td><td>0.784</td><td>1.000</td><td>7708</td><td>tags=46%, list=27%, signal=63%</td></tr><tr><td class='lessen'>126</td><td>ZWANG_EGF_INTERVAL_UP</td><td></td><td>93</td><td>-0.24</td><td>-1.15</td><td>0.189</td><td>0.795</td><td>1.000</td><td>7880</td><td>tags=37%, list=28%, signal=50%</td></tr><tr><td class='lessen'>127</td><td>ODONNELL_METASTASIS_UP</td><td></td><td>66</td><td>-0.29</td><td>-1.15</td><td>0.261</td><td>0.792</td><td>1.000</td><td>4913</td><td>tags=30%, list=17%, signal=37%</td></tr><tr><td class='lessen'>128</td><td>HUANG_DASATINIB_RESISTANCE_DN</td><td></td><td>66</td><td>-0.27</td><td>-1.15</td><td>0.277</td><td>0.802</td><td>1.000</td><td>6989</td><td>tags=29%, list=25%, signal=38%</td></tr><tr><td class='lessen'>129</td><td>JOHNSTONE_PARVB_TARGETS_2_DN</td><td></td><td>339</td><td>-0.25</td><td>-1.14</td><td>0.335</td><td>0.806</td><td>1.000</td><td>5285</td><td>tags=24%, list=19%, signal=29%</td></tr><tr><td class='lessen'>130</td><td>RODWELL_AGING_KIDNEY_DN</td><td></td><td>141</td><td>-0.23</td><td>-1.14</td><td>0.228</td><td>0.806</td><td>1.000</td><td>3678</td><td>tags=18%, list=13%, signal=20%</td></tr><tr><td class='lessen'>131</td><td>MATZUK_SPERMATID_DIFFERENTIATION</td><td></td><td>30</td><td>-0.30</td><td>-1.14</td><td>0.276</td><td>0.802</td><td>1.000</td><td>8552</td><td>tags=40%, list=30%, signal=57%</td></tr><tr><td class='lessen'>132</td><td>SCHAEFFER_PROSTATE_DEVELOPMENT_AND_CANCER_BOX4_DN</td><td></td><td>33</td><td>-0.28</td><td>-1.14</td><td>0.325</td><td>0.803</td><td>1.000</td><td>4874</td><td>tags=27%, list=17%, signal=33%</td></tr><tr><td class='lessen'>133</td><td>VERNELL_RETINOBLASTOMA_PATHWAY_DN</td><td></td><td>22</td><td>-0.33</td><td>-1.14</td><td>0.301</td><td>0.801</td><td>1.000</td><td>6059</td><td>tags=32%, list=21%, signal=40%</td></tr><tr><td class='lessen'>134</td><td>WAKASUGI_HAVE_ZNF143_BINDING_SITES</td><td></td><td>54</td><td>-0.28</td><td>-1.14</td><td>0.327</td><td>0.806</td><td>1.000</td><td>8047</td><td>tags=37%, list=28%, signal=52%</td></tr><tr><td class='lessen'>135</td><td>NOURUZI_NEPC_ASCL1_TARGETS</td><td></td><td>134</td><td>-0.25</td><td>-1.14</td><td>0.230</td><td>0.800</td><td>1.000</td><td>7980</td><td>tags=37%, list=28%, signal=51%</td></tr><tr><td class='lessen'>136</td><td>HOOI_ST7_TARGETS_DN</td><td></td><td>115</td><td>-0.23</td><td>-1.13</td><td>0.189</td><td>0.796</td><td>1.000</td><td>6128</td><td>tags=30%, list=22%, signal=39%</td></tr><tr><td class='lessen'>137</td><td>BILD_SRC_ONCOGENIC_SIGNATURE</td><td></td><td>59</td><td>-0.26</td><td>-1.13</td><td>0.291</td><td>0.797</td><td>1.000</td><td>6305</td><td>tags=29%, list=22%, signal=37%</td></tr><tr><td class='lessen'>138</td><td>ZHENG_FOXP3_TARGETS_IN_T_LYMPHOCYTE_DN</td><td></td><td>38</td><td>-0.34</td><td>-1.13</td><td>0.325</td><td>0.793</td><td>1.000</td><td>7696</td><td>tags=47%, list=27%, signal=65%</td></tr><tr><td class='lessen'>139</td><td>SU_PLACENTA</td><td></td><td>23</td><td>-0.37</td><td>-1.13</td><td>0.314</td><td>0.795</td><td>1.000</td><td>6493</td><td>tags=35%, list=23%, signal=45%</td></tr><tr><td class='lessen'>140</td><td>SMIRNOV_RESPONSE_TO_IR_2HR_DN</td><td></td><td>57</td><td>-0.27</td><td>-1.13</td><td>0.321</td><td>0.793</td><td>1.000</td><td>4746</td><td>tags=28%, list=17%, signal=34%</td></tr><tr><td class='lessen'>141</td><td>MYLLYKANGAS_AMPLIFICATION_HOT_SPOT_23</td><td></td><td>19</td><td>-0.35</td><td>-1.13</td><td>0.337</td><td>0.788</td><td>1.000</td><td>8055</td><td>tags=47%, list=28%, signal=66%</td></tr><tr><td class='lessen'>142</td><td>WEBER_METHYLATED_HCP_IN_SPERM_UP</td><td></td><td>17</td><td>-0.36</td><td>-1.13</td><td>0.249</td><td>0.786</td><td>1.000</td><td>6615</td><td>tags=41%, list=23%, signal=54%</td></tr><tr><td class='lessen'>143</td><td>RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_POORLY_UP</td><td></td><td>235</td><td>-0.24</td><td>-1.13</td><td>0.315</td><td>0.784</td><td>1.000</td><td>8019</td><td>tags=32%, list=28%, signal=45%</td></tr><tr><td class='lessen'>144</td><td>PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN</td><td></td><td>169</td><td>-0.22</td><td>-1.12</td><td>0.340</td><td>0.784</td><td>1.000</td><td>4885</td><td>tags=22%, list=17%, signal=27%</td></tr><tr><td class='lessen'>145</td><td>RICKMAN_TUMOR_DIFFERENTIATED_WELL_VS_MODERATELY_UP</td><td></td><td>103</td><td>-0.24</td><td>-1.12</td><td>0.284</td><td>0.782</td><td>1.000</td><td>6072</td><td>tags=27%, list=21%, signal=34%</td></tr><tr><td class='lessen'>146</td><td>STAMBOLSKY_BOUND_BY_MUTATED_TP53</td><td></td><td>15</td><td>-0.36</td><td>-1.12</td><td>0.306</td><td>0.777</td><td>1.000</td><td>7939</td><td>tags=47%, list=28%, signal=65%</td></tr><tr><td class='lessen'>147</td><td>MEISSNER_BRAIN_HCP_WITH_H3K27ME3</td><td></td><td>196</td><td>-0.24</td><td>-1.12</td><td>0.260</td><td>0.781</td><td>1.000</td><td>6413</td><td>tags=30%, list=23%, signal=38%</td></tr><tr><td class='lessen'>148</td><td>MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN</td><td></td><td>169</td><td>-0.23</td><td>-1.12</td><td>0.300</td><td>0.776</td><td>1.000</td><td>5929</td><td>tags=27%, list=21%, signal=33%</td></tr><tr><td class='lessen'>149</td><td>PYEON_CANCER_HEAD_AND_NECK_VS_CERVICAL_UP</td><td></td><td>190</td><td>-0.25</td><td>-1.12</td><td>0.338</td><td>0.772</td><td>1.000</td><td>5176</td><td>tags=24%, list=18%, signal=29%</td></tr><tr><td class='lessen'>150</td><td>ZHENG_FOXP3_TARGETS_IN_THYMUS_UP</td><td></td><td>198</td><td>-0.23</td><td>-1.12</td><td>0.322</td><td>0.768</td><td>1.000</td><td>5981</td><td>tags=25%, list=21%, signal=32%</td></tr><tr><td class='lessen'>151</td><td>FISCHER_G1_S_CELL_CYCLE</td><td></td><td>198</td><td>-0.25</td><td>-1.12</td><td>0.341</td><td>0.765</td><td>1.000</td><td>2563</td><td>tags=16%, list=9%, signal=18%</td></tr><tr><td class='lessen'>152</td><td>MARTINEZ_RESPONSE_TO_TRABECTEDIN</td><td></td><td>50</td><td>-0.28</td><td>-1.12</td><td>0.342</td><td>0.761</td><td>1.000</td><td>2701</td><td>tags=16%, list=10%, signal=18%</td></tr><tr><td class='lessen'>153</td><td>GRESHOCK_CANCER_COPY_NUMBER_UP</td><td></td><td>303</td><td>-0.21</td><td>-1.12</td><td>0.341</td><td>0.758</td><td>1.000</td><td>8055</td><td>tags=33%, list=28%, signal=46%</td></tr><tr><td class='lessen'>154</td><td>ZHAN_MULTIPLE_MYELOMA_MS_DN</td><td></td><td>42</td><td>-0.28</td><td>-1.12</td><td>0.307</td><td>0.754</td><td>1.000</td><td>3947</td><td>tags=19%, list=14%, signal=22%</td></tr><tr><td class='lessen'>155</td><td>MAEKAWA_ATF2_TARGETS</td><td></td><td>22</td><td>-0.33</td><td>-1.12</td><td>0.288</td><td>0.749</td><td>1.000</td><td>7893</td><td>tags=41%, list=28%, signal=57%</td></tr><tr><td class='lessen'>156</td><td>KIM_PTEN_TARGETS_UP</td><td></td><td>18</td><td>-0.38</td><td>-1.12</td><td>0.333</td><td>0.750</td><td>1.000</td><td>4801</td><td>tags=39%, list=17%, signal=47%</td></tr><tr><td class='lessen'>157</td><td>LEE_AGING_NEOCORTEX_DN</td><td></td><td>62</td><td>-0.26</td><td>-1.11</td><td>0.254</td><td>0.748</td><td>1.000</td><td>3460</td><td>tags=19%, list=12%, signal=22%</td></tr><tr><td class='lessen'>158</td><td>PEDERSEN_METASTASIS_BY_ERBB2_ISOFORM_6</td><td></td><td>26</td><td>-0.31</td><td>-1.11</td><td>0.314</td><td>0.750</td><td>1.000</td><td>8982</td><td>tags=46%, list=32%, signal=67%</td></tr><tr><td class='lessen'>159</td><td>LANDEMAINE_LUNG_METASTASIS</td><td></td><td>21</td><td>-0.36</td><td>-1.11</td><td>0.338</td><td>0.748</td><td>1.000</td><td>4600</td><td>tags=33%, list=16%, signal=40%</td></tr><tr><td class='lessen'>160</td><td>KONDO_PROSTATE_CANCER_HCP_WITH_H3K27ME3</td><td></td><td>84</td><td>-0.23</td><td>-1.11</td><td>0.265</td><td>0.745</td><td>1.000</td><td>6996</td><td>tags=31%, list=25%, signal=41%</td></tr><tr><td class='lessen'>161</td><td>WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_DN</td><td></td><td>24</td><td>-0.34</td><td>-1.11</td><td>0.337</td><td>0.754</td><td>1.000</td><td>4999</td><td>tags=25%, list=18%, signal=30%</td></tr><tr><td class='lessen'>162</td><td>RIZ_ERYTHROID_DIFFERENTIATION_HBZ</td><td></td><td>32</td><td>-0.28</td><td>-1.11</td><td>0.284</td><td>0.750</td><td>1.000</td><td>4360</td><td>tags=28%, list=15%, signal=33%</td></tr><tr><td class='lessen'>163</td><td>SILIGAN_BOUND_BY_EWS_FLT1_FUSION</td><td></td><td>44</td><td>-0.28</td><td>-1.11</td><td>0.320</td><td>0.746</td><td>1.000</td><td>5659</td><td>tags=30%, list=20%, signal=37%</td></tr><tr><td class='lessen'>164</td><td>RODRIGUES_DCC_TARGETS_DN</td><td></td><td>118</td><td>-0.24</td><td>-1.10</td><td>0.328</td><td>0.744</td><td>1.000</td><td>5482</td><td>tags=24%, list=19%, signal=29%</td></tr><tr><td class='lessen'>165</td><td>WEBER_METHYLATED_HCP_IN_FIBROBLAST_DN</td><td></td><td>37</td><td>-0.29</td><td>-1.10</td><td>0.299</td><td>0.747</td><td>1.000</td><td>6615</td><td>tags=30%, list=23%, signal=39%</td></tr><tr><td class='lessen'>166</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREY_UP</td><td></td><td>18</td><td>-0.34</td><td>-1.10</td><td>0.325</td><td>0.749</td><td>1.000</td><td>5268</td><td>tags=33%, list=19%, signal=41%</td></tr><tr><td class='lessen'>167</td><td>TRAYNOR_RETT_SYNDROM_DN</td><td></td><td>15</td><td>-0.35</td><td>-1.10</td><td>0.348</td><td>0.751</td><td>1.000</td><td>3543</td><td>tags=27%, list=12%, signal=30%</td></tr><tr><td class='lessen'>168</td><td>DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN</td><td></td><td>465</td><td>-0.29</td><td>-1.10</td><td>0.395</td><td>0.751</td><td>1.000</td><td>7354</td><td>tags=33%, list=26%, signal=44%</td></tr><tr><td class='lessen'>169</td><td>VANHARANTA_UTERINE_FIBROID_WITH_7Q_DELETION_UP</td><td></td><td>65</td><td>-0.25</td><td>-1.09</td><td>0.378</td><td>0.750</td><td>1.000</td><td>7744</td><td>tags=34%, list=27%, signal=46%</td></tr><tr><td class='lessen'>170</td><td>HAHTOLA_MYCOSIS_FUNGOIDES_CD4_DN</td><td></td><td>112</td><td>-0.25</td><td>-1.09</td><td>0.372</td><td>0.750</td><td>1.000</td><td>6088</td><td>tags=25%, list=21%, signal=32%</td></tr><tr><td class='lessen'>171</td><td>MULLIGHAN_NPM1_MUTATED_SIGNATURE_1_UP</td><td></td><td>250</td><td>-0.22</td><td>-1.09</td><td>0.326</td><td>0.758</td><td>1.000</td><td>6522</td><td>tags=27%, list=23%, signal=35%</td></tr><tr><td class='lessen'>172</td><td>WANG_NEOPLASTIC_TRANSFORMATION_BY_CCND1_MYC</td><td></td><td>20</td><td>-0.34</td><td>-1.09</td><td>0.334</td><td>0.758</td><td>1.000</td><td>5643</td><td>tags=40%, list=20%, signal=50%</td></tr><tr><td class='lessen'>173</td><td>HOFMANN_MYELODYSPLASTIC_SYNDROM_LOW_RISK_UP</td><td></td><td>21</td><td>-0.31</td><td>-1.09</td><td>0.350</td><td>0.756</td><td>1.000</td><td>6059</td><td>tags=29%, list=21%, signal=36%</td></tr><tr><td class='lessen'>174</td><td>KIM_MYC_AMPLIFICATION_TARGETS_DN</td><td></td><td>94</td><td>-0.25</td><td>-1.08</td><td>0.371</td><td>0.769</td><td>1.000</td><td>4113</td><td>tags=23%, list=14%, signal=27%</td></tr><tr><td class='lessen'>175</td><td>NABA_COLLAGENS</td><td></td><td>42</td><td>-0.29</td><td>-1.08</td><td>0.323</td><td>0.765</td><td>1.000</td><td>7278</td><td>tags=36%, list=26%, signal=48%</td></tr><tr><td class='lessen'>176</td><td>MATZUK_MEIOTIC_AND_DNA_REPAIR</td><td></td><td>37</td><td>-0.27</td><td>-1.08</td><td>0.344</td><td>0.763</td><td>1.000</td><td>7253</td><td>tags=35%, list=26%, signal=47%</td></tr><tr><td class='lessen'>177</td><td>KUNINGER_IGF1_VS_PDGFB_TARGETS_UP</td><td></td><td>74</td><td>-0.24</td><td>-1.08</td><td>0.342</td><td>0.762</td><td>1.000</td><td>9826</td><td>tags=43%, list=35%, signal=66%</td></tr><tr><td class='lessen'>178</td><td>TERAO_AOX4_TARGETS_SKIN_DN</td><td></td><td>23</td><td>-0.33</td><td>-1.08</td><td>0.392</td><td>0.758</td><td>1.000</td><td>9415</td><td>tags=48%, list=33%, signal=71%</td></tr><tr><td class='lessen'>179</td><td>LINDGREN_BLADDER_CANCER_CLUSTER_1_UP</td><td></td><td>112</td><td>-0.23</td><td>-1.07</td><td>0.344</td><td>0.761</td><td>1.000</td><td>4648</td><td>tags=21%, list=16%, signal=26%</td></tr><tr><td class='lessen'>180</td><td>VERNELL_RETINOBLASTOMA_PATHWAY_UP</td><td></td><td>68</td><td>-0.27</td><td>-1.07</td><td>0.367</td><td>0.767</td><td>1.000</td><td>4125</td><td>tags=22%, list=15%, signal=26%</td></tr><tr><td class='lessen'>181</td><td>LIU_OVARIAN_CANCER_TUMORS_AND_XENOGRAFTS_XDGS_UP</td><td></td><td>231</td><td>-0.21</td><td>-1.07</td><td>0.354</td><td>0.769</td><td>1.000</td><td>6979</td><td>tags=29%, list=25%, signal=38%</td></tr><tr><td class='lessen'>182</td><td>SCHLESINGER_H3K27ME3_IN_NORMAL_AND_METHYLATED_IN_CANCER</td><td></td><td>20</td><td>-0.33</td><td>-1.07</td><td>0.348</td><td>0.774</td><td>1.000</td><td>5963</td><td>tags=40%, list=21%, signal=51%</td></tr><tr><td class='lessen'>183</td><td>MATZUK_EMBRYONIC_GERM_CELL</td><td></td><td>16</td><td>-0.34</td><td>-1.07</td><td>0.366</td><td>0.770</td><td>1.000</td><td>9065</td><td>tags=38%, list=32%, signal=55%</td></tr><tr><td class='lessen'>184</td><td>LIN_TUMOR_ESCAPE_FROM_IMMUNE_ATTACK</td><td></td><td>16</td><td>-0.34</td><td>-1.07</td><td>0.364</td><td>0.767</td><td>1.000</td><td>3195</td><td>tags=25%, list=11%, signal=28%</td></tr><tr><td class='lessen'>185</td><td>SHETH_LIVER_CANCER_VS_TXNIP_LOSS_PAM5</td><td></td><td>101</td><td>-0.21</td><td>-1.06</td><td>0.330</td><td>0.765</td><td>1.000</td><td>8544</td><td>tags=42%, list=30%, signal=59%</td></tr><tr><td class='lessen'>186</td><td>WESTON_VEGFA_TARGETS_12HR</td><td></td><td>25</td><td>-0.35</td><td>-1.06</td><td>0.388</td><td>0.764</td><td>1.000</td><td>5910</td><td>tags=32%, list=21%, signal=40%</td></tr><tr><td class='lessen'>187</td><td>SHEDDEN_LUNG_CANCER_GOOD_SURVIVAL_A5</td><td></td><td>68</td><td>-0.24</td><td>-1.06</td><td>0.379</td><td>0.761</td><td>1.000</td><td>5839</td><td>tags=25%, list=21%, signal=31%</td></tr><tr><td class='lessen'>188</td><td>HOFMANN_MYELODYSPLASTIC_SYNDROM_HIGH_RISK_DN</td><td></td><td>20</td><td>-0.33</td><td>-1.06</td><td>0.391</td><td>0.759</td><td>1.000</td><td>2952</td><td>tags=30%, list=10%, signal=33%</td></tr><tr><td class='lessen'>189</td><td>CREIGHTON_ENDOCRINE_THERAPY_RESISTANCE_2</td><td></td><td>457</td><td>-0.19</td><td>-1.06</td><td>0.311</td><td>0.764</td><td>1.000</td><td>6094</td><td>tags=25%, list=21%, signal=32%</td></tr><tr><td class='lessen'>190</td><td>CHEN_HOXA5_TARGETS_9HR_UP</td><td></td><td>220</td><td>-0.22</td><td>-1.06</td><td>0.378</td><td>0.760</td><td>1.000</td><td>6134</td><td>tags=30%, list=22%, signal=38%</td></tr><tr><td class='lessen'>191</td><td>MIKKELSEN_ES_ICP_WITH_H3K27ME3</td><td></td><td>35</td><td>-0.28</td><td>-1.06</td><td>0.355</td><td>0.757</td><td>1.000</td><td>6905</td><td>tags=34%, list=24%, signal=45%</td></tr><tr><td class='lessen'>192</td><td>BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_RUXOLITINIB_UP</td><td></td><td>462</td><td>-0.22</td><td>-1.06</td><td>0.360</td><td>0.755</td><td>1.000</td><td>6504</td><td>tags=30%, list=23%, signal=39%</td></tr><tr><td class='lessen'>193</td><td>EPPERT_CE_HSC_LSC</td><td></td><td>40</td><td>-0.28</td><td>-1.06</td><td>0.407</td><td>0.751</td><td>1.000</td><td>6382</td><td>tags=38%, list=22%, signal=48%</td></tr><tr><td class='lessen'>194</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G6_DN</td><td></td><td>19</td><td>-0.31</td><td>-1.06</td><td>0.391</td><td>0.752</td><td>1.000</td><td>1820</td><td>tags=21%, list=6%, signal=22%</td></tr><tr><td class='lessen'>195</td><td>MISIAK_ANAPLASTIC_THYROID_CARCINOMA_DN</td><td></td><td>19</td><td>-0.34</td><td>-1.06</td><td>0.400</td><td>0.748</td><td>1.000</td><td>8130</td><td>tags=47%, list=29%, signal=66%</td></tr><tr><td class='lessen'>196</td><td>SMID_BREAST_CANCER_RELAPSE_IN_BRAIN_DN</td><td></td><td>78</td><td>-0.24</td><td>-1.06</td><td>0.380</td><td>0.747</td><td>1.000</td><td>6823</td><td>tags=33%, list=24%, signal=44%</td></tr><tr><td class='lessen'>197</td><td>DARWICHE_SQUAMOUS_CELL_CARCINOMA_DN</td><td></td><td>169</td><td>-0.19</td><td>-1.05</td><td>0.343</td><td>0.746</td><td>1.000</td><td>2680</td><td>tags=14%, list=9%, signal=16%</td></tr><tr><td class='lessen'>198</td><td>FIGUEROA_AML_METHYLATION_CLUSTER_3_UP</td><td></td><td>158</td><td>-0.20</td><td>-1.05</td><td>0.363</td><td>0.744</td><td>1.000</td><td>8007</td><td>tags=33%, list=28%, signal=46%</td></tr><tr><td class='lessen'>199</td><td>HOLLEMAN_VINCRISTINE_RESISTANCE_B_ALL_UP</td><td></td><td>39</td><td>-0.28</td><td>-1.05</td><td>0.381</td><td>0.755</td><td>1.000</td><td>7473</td><td>tags=41%, list=26%, signal=56%</td></tr><tr><td class='lessen'>200</td><td>KONDO_EZH2_TARGETS</td><td></td><td>210</td><td>-0.20</td><td>-1.05</td><td>0.343</td><td>0.754</td><td>1.000</td><td>6364</td><td>tags=30%, list=22%, signal=38%</td></tr><tr><td class='lessen'>201</td><td>DAZARD_RESPONSE_TO_UV_SCC_DN</td><td></td><td>114</td><td>-0.22</td><td>-1.04</td><td>0.424</td><td>0.757</td><td>1.000</td><td>6783</td><td>tags=28%, list=24%, signal=37%</td></tr><tr><td class='lessen'>202</td><td>BROWNE_HCMV_INFECTION_16HR_UP</td><td></td><td>220</td><td>-0.20</td><td>-1.04</td><td>0.399</td><td>0.758</td><td>1.000</td><td>6267</td><td>tags=27%, list=22%, signal=35%</td></tr><tr><td class='lessen'>203</td><td>SU_THYMUS</td><td></td><td>18</td><td>-0.39</td><td>-1.04</td><td>0.451</td><td>0.763</td><td>1.000</td><td>12683</td><td>tags=72%, list=45%, signal=130%</td></tr><tr><td class='lessen'>204</td><td>BEGUM_TARGETS_OF_PAX3_FOXO1_FUSION_UP</td><td></td><td>59</td><td>-0.26</td><td>-1.03</td><td>0.419</td><td>0.773</td><td>1.000</td><td>4801</td><td>tags=24%, list=17%, signal=28%</td></tr><tr><td class='lessen'>205</td><td>CHEMNITZ_RESPONSE_TO_PROSTAGLANDIN_E2_DN</td><td></td><td>389</td><td>-0.18</td><td>-1.03</td><td>0.393</td><td>0.772</td><td>1.000</td><td>5898</td><td>tags=23%, list=21%, signal=28%</td></tr><tr><td class='lessen'>206</td><td>SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP</td><td></td><td>388</td><td>-0.20</td><td>-1.03</td><td>0.410</td><td>0.775</td><td>1.000</td><td>4326</td><td>tags=19%, list=15%, signal=22%</td></tr><tr><td class='lessen'>207</td><td>YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_2</td><td></td><td>48</td><td>-0.27</td><td>-1.03</td><td>0.415</td><td>0.774</td><td>1.000</td><td>10738</td><td>tags=48%, list=38%, signal=77%</td></tr><tr><td class='lessen'>208</td><td>BOYLAN_MULTIPLE_MYELOMA_C_CLUSTER_DN</td><td></td><td>32</td><td>-0.26</td><td>-1.03</td><td>0.433</td><td>0.774</td><td>1.000</td><td>4418</td><td>tags=19%, list=16%, signal=22%</td></tr><tr><td class='lessen'>209</td><td>CHOW_RASSF1_TARGETS_UP</td><td></td><td>26</td><td>-0.31</td><td>-1.03</td><td>0.429</td><td>0.771</td><td>1.000</td><td>5172</td><td>tags=27%, list=18%, signal=33%</td></tr><tr><td class='lessen'>210</td><td>SOTIRIOU_BREAST_CANCER_GRADE_1_VS_3_DN</td><td></td><td>52</td><td>-0.24</td><td>-1.03</td><td>0.433</td><td>0.768</td><td>1.000</td><td>2502</td><td>tags=15%, list=9%, signal=17%</td></tr><tr><td class='lessen'>211</td><td>MULLIGHAN_NPM1_MUTATED_SIGNATURE_2_UP</td><td></td><td>125</td><td>-0.23</td><td>-1.03</td><td>0.398</td><td>0.764</td><td>1.000</td><td>7714</td><td>tags=34%, list=27%, signal=46%</td></tr><tr><td class='lessen'>212</td><td>GABRIELY_MIR21_TARGETS</td><td></td><td>286</td><td>-0.23</td><td>-1.03</td><td>0.454</td><td>0.766</td><td>1.000</td><td>6398</td><td>tags=27%, list=23%, signal=34%</td></tr><tr><td class='lessen'>213</td><td>YAUCH_HEDGEHOG_SIGNALING_PARACRINE_UP</td><td></td><td>132</td><td>-0.20</td><td>-1.03</td><td>0.397</td><td>0.762</td><td>1.000</td><td>4306</td><td>tags=19%, list=15%, signal=22%</td></tr><tr><td class='lessen'>214</td><td>TAYLOR_METHYLATED_IN_ACUTE_LYMPHOBLASTIC_LEUKEMIA</td><td></td><td>74</td><td>-0.23</td><td>-1.02</td><td>0.424</td><td>0.762</td><td>1.000</td><td>2396</td><td>tags=14%, list=8%, signal=15%</td></tr><tr><td class='lessen'>215</td><td>BOYLAN_MULTIPLE_MYELOMA_C_D_UP</td><td></td><td>137</td><td>-0.20</td><td>-1.02</td><td>0.419</td><td>0.761</td><td>1.000</td><td>4992</td><td>tags=23%, list=18%, signal=27%</td></tr><tr><td class='lessen'>216</td><td>BENPORATH_ES_2</td><td></td><td>39</td><td>-0.24</td><td>-1.02</td><td>0.437</td><td>0.763</td><td>1.000</td><td>3863</td><td>tags=21%, list=14%, signal=24%</td></tr><tr><td class='lessen'>217</td><td>BILD_CTNNB1_ONCOGENIC_SIGNATURE</td><td></td><td>76</td><td>-0.24</td><td>-1.02</td><td>0.445</td><td>0.761</td><td>1.000</td><td>4874</td><td>tags=22%, list=17%, signal=27%</td></tr><tr><td class='lessen'>218</td><td>KORKOLA_YOLK_SAC_TUMOR_UP</td><td></td><td>20</td><td>-0.29</td><td>-1.02</td><td>0.442</td><td>0.766</td><td>1.000</td><td>1403</td><td>tags=15%, list=5%, signal=16%</td></tr><tr><td class='lessen'>219</td><td>MADAN_DPPA4_TARGETS</td><td></td><td>50</td><td>-0.24</td><td>-1.02</td><td>0.440</td><td>0.763</td><td>1.000</td><td>3692</td><td>tags=22%, list=13%, signal=25%</td></tr><tr><td class='lessen'>220</td><td>NIKOLSKY_MUTATED_AND_AMPLIFIED_IN_BREAST_CANCER</td><td></td><td>89</td><td>-0.22</td><td>-1.02</td><td>0.442</td><td>0.763</td><td>1.000</td><td>2677</td><td>tags=17%, list=9%, signal=19%</td></tr><tr><td class='lessen'>221</td><td>LEE_DOUBLE_POLAR_THYMOCYTE</td><td></td><td>28</td><td>-0.30</td><td>-1.01</td><td>0.445</td><td>0.761</td><td>1.000</td><td>1492</td><td>tags=14%, list=5%, signal=15%</td></tr><tr><td class='lessen'>222</td><td>TCGA_GLIOBLASTOMA_COPY_NUMBER_UP</td><td></td><td>71</td><td>-0.23</td><td>-1.01</td><td>0.435</td><td>0.766</td><td>1.000</td><td>6779</td><td>tags=30%, list=24%, signal=39%</td></tr><tr><td class='lessen'>223</td><td>MIKKELSEN_IPS_WITH_HCP_H3K27ME3</td><td></td><td>66</td><td>-0.24</td><td>-1.01</td><td>0.459</td><td>0.765</td><td>1.000</td><td>5864</td><td>tags=26%, list=21%, signal=32%</td></tr><tr><td class='lessen'>224</td><td>KYNG_ENVIRONMENTAL_STRESS_RESPONSE_NOT_BY_GAMMA_IN_WS</td><td></td><td>29</td><td>-0.25</td><td>-1.01</td><td>0.427</td><td>0.764</td><td>1.000</td><td>4106</td><td>tags=21%, list=14%, signal=24%</td></tr><tr><td class='lessen'>225</td><td>MIKKELSEN_MCV6_HCP_WITH_H3K27ME3</td><td></td><td>338</td><td>-0.20</td><td>-1.01</td><td>0.466</td><td>0.761</td><td>1.000</td><td>5237</td><td>tags=23%, list=18%, signal=28%</td></tr><tr><td class='lessen'>226</td><td>VILLANUEVA_LIVER_CANCER_KRT19_UP</td><td></td><td>170</td><td>-0.23</td><td>-1.01</td><td>0.443</td><td>0.758</td><td>1.000</td><td>6554</td><td>tags=28%, list=23%, signal=36%</td></tr><tr><td class='lessen'>227</td><td>JISON_SICKLE_CELL_DISEASE_DN</td><td></td><td>157</td><td>-0.28</td><td>-1.01</td><td>0.471</td><td>0.764</td><td>1.000</td><td>6504</td><td>tags=29%, list=23%, signal=37%</td></tr><tr><td class='lessen'>228</td><td>COLLIS_PRKDC_SUBSTRATES</td><td></td><td>17</td><td>-0.32</td><td>-1.00</td><td>0.450</td><td>0.763</td><td>1.000</td><td>1615</td><td>tags=18%, list=6%, signal=19%</td></tr><tr><td class='lessen'>229</td><td>SUZUKI_RESPONSE_TO_TSA</td><td></td><td>16</td><td>-0.34</td><td>-1.00</td><td>0.479</td><td>0.765</td><td>1.000</td><td>6522</td><td>tags=38%, list=23%, signal=49%</td></tr><tr><td class='lessen'>230</td><td>RAO_BOUND_BY_SALL4_ISOFORM_B</td><td></td><td>480</td><td>-0.18</td><td>-1.00</td><td>0.431</td><td>0.775</td><td>1.000</td><td>6382</td><td>tags=25%, list=22%, signal=32%</td></tr><tr><td class='lessen'>231</td><td>BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_UP</td><td></td><td>292</td><td>-0.22</td><td>-1.00</td><td>0.433</td><td>0.772</td><td>1.000</td><td>6399</td><td>tags=27%, list=23%, signal=35%</td></tr><tr><td class='lessen'>232</td><td>SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP</td><td></td><td>87</td><td>-0.23</td><td>-1.00</td><td>0.491</td><td>0.771</td><td>1.000</td><td>7012</td><td>tags=31%, list=25%, signal=41%</td></tr><tr><td class='lessen'>233</td><td>NIKOLSKY_BREAST_CANCER_21Q22_AMPLICON</td><td></td><td>15</td><td>-0.36</td><td>-0.99</td><td>0.486</td><td>0.770</td><td>1.000</td><td>6403</td><td>tags=40%, list=23%, signal=52%</td></tr><tr><td class='lessen'>234</td><td>GUENTHER_GROWTH_SPHERICAL_VS_ADHERENT_UP</td><td></td><td>20</td><td>-0.31</td><td>-0.99</td><td>0.476</td><td>0.767</td><td>1.000</td><td>3980</td><td>tags=25%, list=14%, signal=29%</td></tr><tr><td class='lessen'>235</td><td>DE_YY1_TARGETS_DN</td><td></td><td>92</td><td>-0.27</td><td>-0.99</td><td>0.494</td><td>0.766</td><td>1.000</td><td>5146</td><td>tags=28%, list=18%, signal=34%</td></tr><tr><td class='lessen'>236</td><td>ZHOU_INFLAMMATORY_RESPONSE_FIMA_DN</td><td></td><td>267</td><td>-0.19</td><td>-0.99</td><td>0.460</td><td>0.771</td><td>1.000</td><td>8402</td><td>tags=35%, list=30%, signal=49%</td></tr><tr><td class='lessen'>237</td><td>ASGHARZADEH_NEUROBLASTOMA_POOR_SURVIVAL_DN</td><td></td><td>42</td><td>-0.25</td><td>-0.99</td><td>0.490</td><td>0.776</td><td>1.000</td><td>7706</td><td>tags=43%, list=27%, signal=59%</td></tr><tr><td class='lessen'>238</td><td>FINETTI_BREAST_CANCERS_KINOME_GRAY</td><td></td><td>15</td><td>-0.40</td><td>-0.99</td><td>0.518</td><td>0.774</td><td>1.000</td><td>2800</td><td>tags=27%, list=10%, signal=30%</td></tr><tr><td class='lessen'>239</td><td>DING_LUNG_CANCER_MUTATED_SIGNIFICANTLY</td><td></td><td>23</td><td>-0.28</td><td>-0.98</td><td>0.478</td><td>0.776</td><td>1.000</td><td>7461</td><td>tags=43%, list=26%, signal=59%</td></tr><tr><td class='lessen'>240</td><td>BRUINS_UVC_RESPONSE_EARLY_LATE</td><td></td><td>305</td><td>-0.17</td><td>-0.98</td><td>0.471</td><td>0.774</td><td>1.000</td><td>5518</td><td>tags=20%, list=19%, signal=24%</td></tr><tr><td class='lessen'>241</td><td>NIKOLSKY_BREAST_CANCER_20Q12_Q13_AMPLICON</td><td></td><td>131</td><td>-0.19</td><td>-0.98</td><td>0.501</td><td>0.775</td><td>1.000</td><td>4622</td><td>tags=20%, list=16%, signal=24%</td></tr><tr><td class='lessen'>242</td><td>HOLLERN_EMT_BREAST_TUMOR_DN</td><td></td><td>114</td><td>-0.25</td><td>-0.98</td><td>0.503</td><td>0.774</td><td>1.000</td><td>3812</td><td>tags=19%, list=13%, signal=22%</td></tr><tr><td class='lessen'>243</td><td>MINGUEZ_LIVER_CANCER_VASCULAR_INVASION_DN</td><td></td><td>19</td><td>-0.35</td><td>-0.98</td><td>0.499</td><td>0.772</td><td>1.000</td><td>6460</td><td>tags=47%, list=23%, signal=61%</td></tr><tr><td class='lessen'>244</td><td>PARK_HSC_VS_MULTIPOTENT_PROGENITORS_UP</td><td></td><td>19</td><td>-0.33</td><td>-0.98</td><td>0.512</td><td>0.770</td><td>1.000</td><td>2452</td><td>tags=21%, list=9%, signal=23%</td></tr><tr><td class='lessen'>245</td><td>EBAUER_TARGETS_OF_PAX3_FOXO1_FUSION_DN</td><td></td><td>43</td><td>-0.26</td><td>-0.98</td><td>0.490</td><td>0.767</td><td>1.000</td><td>7829</td><td>tags=28%, list=28%, signal=38%</td></tr><tr><td class='lessen'>246</td><td>SARTIPY_NORMAL_AT_INSULIN_RESISTANCE_DN</td><td></td><td>19</td><td>-0.30</td><td>-0.98</td><td>0.461</td><td>0.766</td><td>1.000</td><td>5639</td><td>tags=32%, list=20%, signal=39%</td></tr><tr><td class='lessen'>247</td><td>MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_UP</td><td></td><td>110</td><td>-0.22</td><td>-0.98</td><td>0.475</td><td>0.769</td><td>1.000</td><td>6996</td><td>tags=31%, list=25%, signal=41%</td></tr><tr><td class='lessen'>248</td><td>SHI_SPARC_TARGETS_UP</td><td></td><td>22</td><td>-0.28</td><td>-0.98</td><td>0.498</td><td>0.768</td><td>1.000</td><td>3886</td><td>tags=23%, list=14%, signal=26%</td></tr><tr><td class='lessen'>249</td><td>SHEN_SMARCA2_TARGETS_UP</td><td></td><td>427</td><td>-0.25</td><td>-0.97</td><td>0.502</td><td>0.768</td><td>1.000</td><td>5885</td><td>tags=24%, list=21%, signal=30%</td></tr><tr><td class='lessen'>250</td><td>HOFMANN_MYELODYSPLASTIC_SYNDROM_RISK_DN</td><td></td><td>21</td><td>-0.28</td><td>-0.97</td><td>0.494</td><td>0.767</td><td>1.000</td><td>4901</td><td>tags=33%, list=17%, signal=40%</td></tr><tr><td class='lessen'>251</td><td>NAKAMURA_CANCER_MICROENVIRONMENT_UP</td><td></td><td>23</td><td>-0.27</td><td>-0.97</td><td>0.538</td><td>0.775</td><td>1.000</td><td>5910</td><td>tags=35%, list=21%, signal=44%</td></tr><tr><td class='lessen'>252</td><td>GINESTIER_BREAST_CANCER_ZNF217_AMPLIFIED_UP</td><td></td><td>67</td><td>-0.27</td><td>-0.97</td><td>0.504</td><td>0.773</td><td>1.000</td><td>7273</td><td>tags=30%, list=26%, signal=40%</td></tr><tr><td class='lessen'>253</td><td>MIKKELSEN_MEF_ICP_WITH_H3K4ME3_AND_H3K27ME3</td><td></td><td>31</td><td>-0.26</td><td>-0.96</td><td>0.551</td><td>0.780</td><td>1.000</td><td>5434</td><td>tags=29%, list=19%, signal=36%</td></tr><tr><td class='lessen'>254</td><td>KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION</td><td></td><td>73</td><td>-0.20</td><td>-0.96</td><td>0.545</td><td>0.781</td><td>1.000</td><td>3569</td><td>tags=16%, list=13%, signal=19%</td></tr><tr><td class='lessen'>255</td><td>RICKMAN_METASTASIS_UP</td><td></td><td>342</td><td>-0.17</td><td>-0.96</td><td>0.537</td><td>0.783</td><td>1.000</td><td>6559</td><td>tags=24%, list=23%, signal=30%</td></tr><tr><td class='lessen'>256</td><td>NOUZOVA_TRETINOIN_AND_H4_ACETYLATION</td><td></td><td>135</td><td>-0.20</td><td>-0.96</td><td>0.535</td><td>0.791</td><td>1.000</td><td>4545</td><td>tags=20%, list=16%, signal=24%</td></tr><tr><td class='lessen'>257</td><td>BREDEMEYER_RAG_SIGNALING_NOT_VIA_ATM_UP</td><td></td><td>65</td><td>-0.21</td><td>-0.95</td><td>0.519</td><td>0.794</td><td>1.000</td><td>3080</td><td>tags=15%, list=11%, signal=17%</td></tr><tr><td class='lessen'>258</td><td>FIGUEROA_AML_METHYLATION_CLUSTER_2_UP</td><td></td><td>49</td><td>-0.21</td><td>-0.95</td><td>0.566</td><td>0.792</td><td>1.000</td><td>7725</td><td>tags=35%, list=27%, signal=48%</td></tr><tr><td class='lessen'>259</td><td>XIE_ST_HSC_S1PR3_OE_DN</td><td></td><td>23</td><td>-0.30</td><td>-0.95</td><td>0.490</td><td>0.791</td><td>1.000</td><td>2396</td><td>tags=22%, list=8%, signal=24%</td></tr><tr><td class='lessen'>260</td><td>BURTON_ADIPOGENESIS_12</td><td></td><td>32</td><td>-0.30</td><td>-0.95</td><td>0.508</td><td>0.789</td><td>1.000</td><td>6921</td><td>tags=31%, list=24%, signal=41%</td></tr><tr><td class='lessen'>261</td><td>DARWICHE_SKIN_TUMOR_PROMOTER_DN</td><td></td><td>174</td><td>-0.18</td><td>-0.95</td><td>0.556</td><td>0.787</td><td>1.000</td><td>2532</td><td>tags=14%, list=9%, signal=15%</td></tr><tr><td class='lessen'>262</td><td>COLDREN_GEFITINIB_RESISTANCE_DN</td><td></td><td>218</td><td>-0.18</td><td>-0.95</td><td>0.561</td><td>0.786</td><td>1.000</td><td>5424</td><td>tags=22%, list=19%, signal=28%</td></tr><tr><td class='lessen'>263</td><td>FLORIO_NEOCORTEX_BASAL_RADIAL_GLIA_UP</td><td></td><td>344</td><td>-0.19</td><td>-0.95</td><td>0.556</td><td>0.788</td><td>1.000</td><td>7476</td><td>tags=32%, list=26%, signal=43%</td></tr><tr><td class='lessen'>264</td><td>SCHAEFFER_SOX9_TARGETS_IN_PROSTATE_DEVELOPMENT_DN</td><td></td><td>42</td><td>-0.25</td><td>-0.94</td><td>0.560</td><td>0.797</td><td>1.000</td><td>8748</td><td>tags=38%, list=31%, signal=55%</td></tr><tr><td class='lessen'>265</td><td>KOHN_EMT_EPITHELIAL</td><td></td><td>21</td><td>-0.34</td><td>-0.94</td><td>0.546</td><td>0.795</td><td>1.000</td><td>7619</td><td>tags=38%, list=27%, signal=52%</td></tr><tr><td class='lessen'>266</td><td>JAERVINEN_AMPLIFIED_IN_LARYNGEAL_CANCER</td><td></td><td>40</td><td>-0.24</td><td>-0.94</td><td>0.568</td><td>0.793</td><td>1.000</td><td>7505</td><td>tags=35%, list=26%, signal=48%</td></tr><tr><td class='lessen'>267</td><td>KAAB_FAILED_HEART_ATRIUM_UP</td><td></td><td>30</td><td>-0.22</td><td>-0.94</td><td>0.603</td><td>0.792</td><td>1.000</td><td>6674</td><td>tags=27%, list=24%, signal=35%</td></tr><tr><td class='lessen'>268</td><td>WATANABE_COLON_CANCER_MSI_VS_MSS_DN</td><td></td><td>60</td><td>-0.21</td><td>-0.94</td><td>0.590</td><td>0.797</td><td>1.000</td><td>3280</td><td>tags=20%, list=12%, signal=23%</td></tr><tr><td class='lessen'>269</td><td>DING_LUNG_CANCER_BY_MUTATION_RATE</td><td></td><td>19</td><td>-0.28</td><td>-0.94</td><td>0.572</td><td>0.795</td><td>1.000</td><td>3199</td><td>tags=21%, list=11%, signal=24%</td></tr><tr><td class='lessen'>270</td><td>FOURNIER_ACINAR_DEVELOPMENT_EARLY_UP</td><td></td><td>20</td><td>-0.29</td><td>-0.94</td><td>0.554</td><td>0.794</td><td>1.000</td><td>3086</td><td>tags=25%, list=11%, signal=28%</td></tr><tr><td class='lessen'>271</td><td>MIKKELSEN_MEF_HCP_WITH_H3K27ME3</td><td></td><td>448</td><td>-0.19</td><td>-0.93</td><td>0.697</td><td>0.801</td><td>1.000</td><td>5864</td><td>tags=25%, list=21%, signal=32%</td></tr><tr><td class='lessen'>272</td><td>JINESH_BLEBBISHIELD_VS_LIVE_CONTROL_UP</td><td></td><td>363</td><td>-0.18</td><td>-0.93</td><td>0.512</td><td>0.799</td><td>1.000</td><td>6497</td><td>tags=27%, list=23%, signal=35%</td></tr><tr><td class='lessen'>273</td><td>GENTILE_UV_RESPONSE_CLUSTER_D5</td><td></td><td>35</td><td>-0.22</td><td>-0.93</td><td>0.580</td><td>0.809</td><td>1.000</td><td>4573</td><td>tags=23%, list=16%, signal=27%</td></tr><tr><td class='lessen'>274</td><td>SCHWAB_TARGETS_OF_BMYB_POLYMORPHIC_VARIANTS_DN</td><td></td><td>16</td><td>-0.29</td><td>-0.92</td><td>0.540</td><td>0.809</td><td>1.000</td><td>4807</td><td>tags=31%, list=17%, signal=38%</td></tr><tr><td class='lessen'>275</td><td>DAVICIONI_MOLECULAR_ARMS_VS_ERMS_UP</td><td></td><td>324</td><td>-0.17</td><td>-0.92</td><td>0.602</td><td>0.822</td><td>1.000</td><td>8170</td><td>tags=32%, list=29%, signal=45%</td></tr><tr><td class='lessen'>276</td><td>RODRIGUES_THYROID_CARCINOMA_DN</td><td></td><td>75</td><td>-0.21</td><td>-0.92</td><td>0.584</td><td>0.823</td><td>1.000</td><td>3141</td><td>tags=19%, list=11%, signal=21%</td></tr><tr><td class='lessen'>277</td><td>TIEN_INTESTINE_PROBIOTICS_2HR_DN</td><td></td><td>88</td><td>-0.19</td><td>-0.91</td><td>0.620</td><td>0.826</td><td>1.000</td><td>7188</td><td>tags=28%, list=25%, signal=38%</td></tr><tr><td class='lessen'>278</td><td>KYNG_NORMAL_AGING_DN</td><td></td><td>18</td><td>-0.29</td><td>-0.91</td><td>0.597</td><td>0.826</td><td>1.000</td><td>3502</td><td>tags=22%, list=12%, signal=25%</td></tr><tr><td class='lessen'>279</td><td>MIKKELSEN_MEF_HCP_WITH_H3_UNMETHYLATED</td><td></td><td>187</td><td>-0.18</td><td>-0.91</td><td>0.694</td><td>0.823</td><td>1.000</td><td>5747</td><td>tags=22%, list=20%, signal=28%</td></tr><tr><td class='lessen'>280</td><td>KANG_FLUOROURACIL_RESISTANCE_UP</td><td></td><td>22</td><td>-0.26</td><td>-0.91</td><td>0.637</td><td>0.821</td><td>1.000</td><td>6413</td><td>tags=32%, list=23%, signal=41%</td></tr><tr><td class='lessen'>281</td><td>VETTER_TARGETS_OF_PRKCA_AND_ETS1_UP</td><td></td><td>16</td><td>-0.30</td><td>-0.91</td><td>0.607</td><td>0.819</td><td>1.000</td><td>3857</td><td>tags=31%, list=14%, signal=36%</td></tr><tr><td class='lessen'>282</td><td>MAYBURD_RESPONSE_TO_L663536_DN</td><td></td><td>52</td><td>-0.22</td><td>-0.91</td><td>0.610</td><td>0.817</td><td>1.000</td><td>3999</td><td>tags=21%, list=14%, signal=25%</td></tr><tr><td class='lessen'>283</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_GREEN_DN</td><td></td><td>24</td><td>-0.28</td><td>-0.91</td><td>0.582</td><td>0.825</td><td>1.000</td><td>6292</td><td>tags=33%, list=22%, signal=43%</td></tr><tr><td class='lessen'>284</td><td>DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_DN</td><td></td><td>19</td><td>-0.27</td><td>-0.90</td><td>0.586</td><td>0.824</td><td>1.000</td><td>4061</td><td>tags=32%, list=14%, signal=37%</td></tr><tr><td class='lessen'>285</td><td>WILLIAMS_ESR1_TARGETS_UP</td><td></td><td>24</td><td>-0.28</td><td>-0.90</td><td>0.596</td><td>0.823</td><td>1.000</td><td>5211</td><td>tags=25%, list=18%, signal=31%</td></tr><tr><td class='lessen'>286</td><td>LEIN_MIDBRAIN_MARKERS</td><td></td><td>72</td><td>-0.21</td><td>-0.90</td><td>0.651</td><td>0.820</td><td>1.000</td><td>1408</td><td>tags=11%, list=5%, signal=12%</td></tr><tr><td class='lessen'>287</td><td>BOYAULT_LIVER_CANCER_SUBCLASS_G1_UP</td><td></td><td>111</td><td>-0.18</td><td>-0.90</td><td>0.658</td><td>0.822</td><td>1.000</td><td>6056</td><td>tags=23%, list=21%, signal=29%</td></tr><tr><td class='lessen'>288</td><td>GARCIA_TARGETS_OF_FLI1_AND_DAX1_DN</td><td></td><td>156</td><td>-0.19</td><td>-0.90</td><td>0.656</td><td>0.821</td><td>1.000</td><td>6327</td><td>tags=23%, list=22%, signal=30%</td></tr><tr><td class='lessen'>289</td><td>DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN</td><td></td><td>322</td><td>-0.19</td><td>-0.90</td><td>0.557</td><td>0.818</td><td>1.000</td><td>6047</td><td>tags=24%, list=21%, signal=30%</td></tr><tr><td class='lessen'>290</td><td>MILI_PSEUDOPODIA</td><td></td><td>48</td><td>-0.25</td><td>-0.90</td><td>0.588</td><td>0.816</td><td>1.000</td><td>8684</td><td>tags=35%, list=31%, signal=51%</td></tr><tr><td class='lessen'>291</td><td>DEBOSSCHER_NFKB_TARGETS_REPRESSED_BY_GLUCOCORTICOIDS</td><td></td><td>18</td><td>-0.28</td><td>-0.90</td><td>0.619</td><td>0.814</td><td>1.000</td><td>6921</td><td>tags=33%, list=24%, signal=44%</td></tr><tr><td class='lessen'>292</td><td>GARY_CD5_TARGETS_DN</td><td></td><td>425</td><td>-0.19</td><td>-0.90</td><td>0.559</td><td>0.820</td><td>1.000</td><td>6384</td><td>tags=24%, list=22%, signal=30%</td></tr><tr><td class='lessen'>293</td><td>ZHENG_BOUND_BY_FOXP3</td><td></td><td>490</td><td>-0.16</td><td>-0.89</td><td>0.609</td><td>0.824</td><td>1.000</td><td>7732</td><td>tags=28%, list=27%, signal=38%</td></tr><tr><td class='lessen'>294</td><td>ROYLANCE_BREAST_CANCER_16Q_COPY_NUMBER_UP</td><td></td><td>61</td><td>-0.19</td><td>-0.89</td><td>0.665</td><td>0.823</td><td>1.000</td><td>4874</td><td>tags=20%, list=17%, signal=24%</td></tr><tr><td class='lessen'>295</td><td>WENG_POR_TARGETS_LIVER_DN</td><td></td><td>19</td><td>-0.29</td><td>-0.89</td><td>0.603</td><td>0.823</td><td>1.000</td><td>1820</td><td>tags=16%, list=6%, signal=17%</td></tr><tr><td class='lessen'>296</td><td>HOFMANN_CELL_LYMPHOMA_UP</td><td></td><td>45</td><td>-0.21</td><td>-0.89</td><td>0.655</td><td>0.821</td><td>1.000</td><td>9650</td><td>tags=42%, list=34%, signal=64%</td></tr><tr><td class='lessen'>297</td><td>LI_CYTIDINE_ANALOGS_CYCTOTOXICITY</td><td></td><td>15</td><td>-0.32</td><td>-0.89</td><td>0.608</td><td>0.822</td><td>1.000</td><td>8549</td><td>tags=53%, list=30%, signal=76%</td></tr><tr><td class='lessen'>298</td><td>NIKOLSKY_BREAST_CANCER_15Q26_AMPLICON</td><td></td><td>21</td><td>-0.26</td><td>-0.89</td><td>0.590</td><td>0.819</td><td>1.000</td><td>1464</td><td>tags=14%, list=5%, signal=15%</td></tr><tr><td class='lessen'>299</td><td>WHITFIELD_CELL_CYCLE_M_G1</td><td></td><td>121</td><td>-0.21</td><td>-0.88</td><td>0.606</td><td>0.826</td><td>1.000</td><td>6930</td><td>tags=30%, list=24%, signal=39%</td></tr><tr><td class='lessen'>300</td><td>YANG_BREAST_CANCER_ESR1_LASER_UP</td><td></td><td>29</td><td>-0.24</td><td>-0.88</td><td>0.661</td><td>0.824</td><td>1.000</td><td>2391</td><td>tags=14%, list=8%, signal=15%</td></tr><tr><td class='lessen'>301</td><td>XU_GH1_EXOGENOUS_TARGETS_DN</td><td></td><td>92</td><td>-0.17</td><td>-0.88</td><td>0.774</td><td>0.823</td><td>1.000</td><td>8336</td><td>tags=33%, list=29%, signal=46%</td></tr><tr><td class='lessen'>302</td><td>RAO_BOUND_BY_SALL4_ISOFORM_A</td><td></td><td>153</td><td>-0.19</td><td>-0.88</td><td>0.649</td><td>0.822</td><td>1.000</td><td>2722</td><td>tags=14%, list=10%, signal=16%</td></tr><tr><td class='lessen'>303</td><td>RICKMAN_HEAD_AND_NECK_CANCER_A</td><td></td><td>93</td><td>-0.20</td><td>-0.88</td><td>0.718</td><td>0.825</td><td>1.000</td><td>7754</td><td>tags=34%, list=27%, signal=47%</td></tr><tr><td class='lessen'>304</td><td>SANSOM_APC_TARGETS</td><td></td><td>188</td><td>-0.19</td><td>-0.88</td><td>0.644</td><td>0.823</td><td>1.000</td><td>7199</td><td>tags=29%, list=25%, signal=38%</td></tr><tr><td class='lessen'>305</td><td>HEBERT_MATRISOME_TNBC_LUNG_METASTASIS</td><td></td><td>22</td><td>-0.26</td><td>-0.88</td><td>0.669</td><td>0.823</td><td>1.000</td><td>5827</td><td>tags=32%, list=21%, signal=40%</td></tr><tr><td class='lessen'>306</td><td>SU_PANCREAS</td><td></td><td>41</td><td>-0.23</td><td>-0.88</td><td>0.648</td><td>0.822</td><td>1.000</td><td>2029</td><td>tags=12%, list=7%, signal=13%</td></tr><tr><td class='lessen'>307</td><td>LEE_DIFFERENTIATING_T_LYMPHOCYTE</td><td></td><td>199</td><td>-0.23</td><td>-0.88</td><td>0.586</td><td>0.820</td><td>1.000</td><td>10854</td><td>tags=43%, list=38%, signal=69%</td></tr><tr><td class='lessen'>308</td><td>BROWNE_HCMV_INFECTION_12HR_DN</td><td></td><td>96</td><td>-0.20</td><td>-0.87</td><td>0.674</td><td>0.822</td><td>1.000</td><td>7112</td><td>tags=26%, list=25%, signal=35%</td></tr><tr><td class='lessen'>309</td><td>FARMER_BREAST_CANCER_CLUSTER_5</td><td></td><td>19</td><td>-0.24</td><td>-0.87</td><td>0.640</td><td>0.824</td><td>1.000</td><td>1584</td><td>tags=11%, list=6%, signal=11%</td></tr><tr><td class='lessen'>310</td><td>MIKKELSEN_MEF_LCP_WITH_H3K27ME3</td><td></td><td>55</td><td>-0.24</td><td>-0.87</td><td>0.677</td><td>0.824</td><td>1.000</td><td>10161</td><td>tags=40%, list=36%, signal=62%</td></tr><tr><td class='lessen'>311</td><td>MIKKELSEN_MEF_ICP_WITH_H3K27ME3</td><td></td><td>165</td><td>-0.20</td><td>-0.87</td><td>0.743</td><td>0.822</td><td>1.000</td><td>7678</td><td>tags=34%, list=27%, signal=46%</td></tr><tr><td class='lessen'>312</td><td>KORKOLA_EMBRYONIC_CARCINOMA_VS_SEMINOMA_DN</td><td></td><td>22</td><td>-0.28</td><td>-0.87</td><td>0.639</td><td>0.821</td><td>1.000</td><td>5832</td><td>tags=27%, list=21%, signal=34%</td></tr><tr><td class='lessen'>313</td><td>VALK_AML_CLUSTER_1</td><td></td><td>29</td><td>-0.23</td><td>-0.87</td><td>0.634</td><td>0.820</td><td>1.000</td><td>1827</td><td>tags=14%, list=6%, signal=15%</td></tr><tr><td class='lessen'>314</td><td>IKEDA_MIR30_TARGETS_UP</td><td></td><td>115</td><td>-0.23</td><td>-0.87</td><td>0.590</td><td>0.821</td><td>1.000</td><td>7696</td><td>tags=35%, list=27%, signal=48%</td></tr><tr><td class='lessen'>315</td><td>HOWLIN_CITED1_TARGETS_2_UP</td><td></td><td>17</td><td>-0.31</td><td>-0.87</td><td>0.596</td><td>0.819</td><td>1.000</td><td>9544</td><td>tags=47%, list=34%, signal=71%</td></tr><tr><td class='lessen'>316</td><td>BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_CELLS_DN</td><td></td><td>64</td><td>-0.23</td><td>-0.86</td><td>0.676</td><td>0.820</td><td>1.000</td><td>5613</td><td>tags=27%, list=20%, signal=33%</td></tr><tr><td class='lessen'>317</td><td>LOPES_METHYLATED_IN_COLON_CANCER_UP</td><td></td><td>24</td><td>-0.29</td><td>-0.86</td><td>0.628</td><td>0.818</td><td>1.000</td><td>6140</td><td>tags=42%, list=22%, signal=53%</td></tr><tr><td class='lessen'>318</td><td>YAGI_AML_WITH_T_9_11_TRANSLOCATION</td><td></td><td>124</td><td>-0.18</td><td>-0.86</td><td>0.690</td><td>0.823</td><td>1.000</td><td>7505</td><td>tags=31%, list=26%, signal=41%</td></tr><tr><td class='lessen'>319</td><td>WANG_TNF_TARGETS</td><td></td><td>19</td><td>-0.25</td><td>-0.86</td><td>0.680</td><td>0.823</td><td>1.000</td><td>4299</td><td>tags=26%, list=15%, signal=31%</td></tr><tr><td class='lessen'>320</td><td>FERRANDO_HOX11_NEIGHBORS</td><td></td><td>22</td><td>-0.28</td><td>-0.86</td><td>0.622</td><td>0.823</td><td>1.000</td><td>7182</td><td>tags=41%, list=25%, signal=55%</td></tr><tr><td class='lessen'>321</td><td>REN_ALVEOLAR_RHABDOMYOSARCOMA_UP</td><td></td><td>91</td><td>-0.20</td><td>-0.86</td><td>0.762</td><td>0.821</td><td>1.000</td><td>6007</td><td>tags=24%, list=21%, signal=31%</td></tr><tr><td class='lessen'>322</td><td>MISSIAGLIA_REGULATED_BY_METHYLATION_DN</td><td></td><td>121</td><td>-0.18</td><td>-0.85</td><td>0.708</td><td>0.823</td><td>1.000</td><td>5823</td><td>tags=21%, list=21%, signal=27%</td></tr><tr><td class='lessen'>323</td><td>KIM_MYCL1_AMPLIFICATION_TARGETS_DN</td><td></td><td>20</td><td>-0.27</td><td>-0.85</td><td>0.672</td><td>0.821</td><td>1.000</td><td>3812</td><td>tags=25%, list=13%, signal=29%</td></tr><tr><td class='lessen'>324</td><td>WHITFIELD_CELL_CYCLE_S</td><td></td><td>148</td><td>-0.19</td><td>-0.85</td><td>0.654</td><td>0.827</td><td>1.000</td><td>6641</td><td>tags=26%, list=23%, signal=33%</td></tr><tr><td class='lessen'>325</td><td>HOSHIDA_LIVER_CANCER_SUBCLASS_S2</td><td></td><td>104</td><td>-0.19</td><td>-0.85</td><td>0.684</td><td>0.828</td><td>1.000</td><td>4076</td><td>tags=16%, list=14%, signal=19%</td></tr><tr><td class='lessen'>326</td><td>KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN</td><td></td><td>58</td><td>-0.27</td><td>-0.85</td><td>0.601</td><td>0.827</td><td>1.000</td><td>6716</td><td>tags=33%, list=24%, signal=43%</td></tr><tr><td class='lessen'>327</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_BLUE_DN</td><td></td><td>61</td><td>-0.21</td><td>-0.84</td><td>0.658</td><td>0.830</td><td>1.000</td><td>6019</td><td>tags=26%, list=21%, signal=33%</td></tr><tr><td class='lessen'>328</td><td>MIKKELSEN_MCV6_ICP_WITH_H3K4ME3_AND_H3K27ME3</td><td></td><td>28</td><td>-0.25</td><td>-0.84</td><td>0.748</td><td>0.832</td><td>1.000</td><td>3222</td><td>tags=18%, list=11%, signal=20%</td></tr><tr><td class='lessen'>329</td><td>MEISSNER_BRAIN_HCP_WITH_H3K4ME2_AND_H3K27ME3</td><td></td><td>53</td><td>-0.19</td><td>-0.84</td><td>0.741</td><td>0.830</td><td>1.000</td><td>1875</td><td>tags=11%, list=7%, signal=12%</td></tr><tr><td class='lessen'>330</td><td>BALDWIN_PRKCI_TARGETS_UP</td><td></td><td>39</td><td>-0.23</td><td>-0.84</td><td>0.671</td><td>0.834</td><td>1.000</td><td>5561</td><td>tags=28%, list=20%, signal=35%</td></tr><tr><td class='lessen'>331</td><td>MOLENAAR_TARGETS_OF_CCND1_AND_CDK4_UP</td><td></td><td>67</td><td>-0.21</td><td>-0.84</td><td>0.703</td><td>0.835</td><td>1.000</td><td>4633</td><td>tags=19%, list=16%, signal=23%</td></tr><tr><td class='lessen'>332</td><td>GAZDA_DIAMOND_BLACKFAN_ANEMIA_PROGENITOR_DN</td><td></td><td>64</td><td>-0.21</td><td>-0.83</td><td>0.697</td><td>0.841</td><td>1.000</td><td>7375</td><td>tags=31%, list=26%, signal=42%</td></tr><tr><td class='lessen'>333</td><td>HOLLEMAN_ASPARAGINASE_RESISTANCE_ALL_DN</td><td></td><td>25</td><td>-0.26</td><td>-0.83</td><td>0.656</td><td>0.840</td><td>1.000</td><td>5651</td><td>tags=32%, list=20%, signal=40%</td></tr><tr><td class='lessen'>334</td><td>KIM_WT1_TARGETS_DN</td><td></td><td>454</td><td>-0.15</td><td>-0.83</td><td>0.744</td><td>0.837</td><td>1.000</td><td>5972</td><td>tags=20%, list=21%, signal=25%</td></tr><tr><td class='lessen'>335</td><td>MIKKELSEN_IPS_ICP_WITH_H3K27ME3</td><td></td><td>41</td><td>-0.21</td><td>-0.83</td><td>0.788</td><td>0.836</td><td>1.000</td><td>8635</td><td>tags=34%, list=30%, signal=49%</td></tr><tr><td class='lessen'>336</td><td>NIKOLSKY_BREAST_CANCER_8Q23_Q24_AMPLICON</td><td></td><td>148</td><td>-0.19</td><td>-0.83</td><td>0.732</td><td>0.834</td><td>1.000</td><td>5247</td><td>tags=20%, list=18%, signal=25%</td></tr><tr><td class='lessen'>337</td><td>BEIER_GLIOMA_STEM_CELL_UP</td><td></td><td>35</td><td>-0.22</td><td>-0.83</td><td>0.725</td><td>0.833</td><td>1.000</td><td>5885</td><td>tags=26%, list=21%, signal=32%</td></tr><tr><td class='lessen'>338</td><td>RAMASWAMY_METASTASIS_DN</td><td></td><td>58</td><td>-0.21</td><td>-0.83</td><td>0.733</td><td>0.832</td><td>1.000</td><td>2129</td><td>tags=14%, list=7%, signal=15%</td></tr><tr><td class='lessen'>339</td><td>TOYOTA_TARGETS_OF_MIR34B_AND_MIR34C</td><td></td><td>451</td><td>-0.15</td><td>-0.83</td><td>0.771</td><td>0.831</td><td>1.000</td><td>7948</td><td>tags=29%, list=28%, signal=39%</td></tr><tr><td class='lessen'>340</td><td>ZWANG_CLASS_2_TRANSIENTLY_INDUCED_BY_EGF</td><td></td><td>50</td><td>-0.20</td><td>-0.82</td><td>0.786</td><td>0.834</td><td>1.000</td><td>7945</td><td>tags=38%, list=28%, signal=53%</td></tr><tr><td class='lessen'>341</td><td>FIGUEROA_AML_METHYLATION_CLUSTER_4_DN</td><td></td><td>15</td><td>-0.25</td><td>-0.82</td><td>0.726</td><td>0.833</td><td>1.000</td><td>10985</td><td>tags=53%, list=39%, signal=87%</td></tr><tr><td class='lessen'>342</td><td>STARK_HYPPOCAMPUS_22Q11_DELETION_UP</td><td></td><td>52</td><td>-0.19</td><td>-0.82</td><td>0.742</td><td>0.831</td><td>1.000</td><td>5856</td><td>tags=25%, list=21%, signal=31%</td></tr><tr><td class='lessen'>343</td><td>WIKMAN_ASBESTOS_LUNG_CANCER_UP</td><td></td><td>17</td><td>-0.27</td><td>-0.81</td><td>0.732</td><td>0.847</td><td>1.000</td><td>1841</td><td>tags=12%, list=6%, signal=13%</td></tr><tr><td class='lessen'>344</td><td>KAUFFMANN_MELANOMA_RELAPSE_UP</td><td></td><td>61</td><td>-0.20</td><td>-0.81</td><td>0.706</td><td>0.846</td><td>1.000</td><td>8073</td><td>tags=33%, list=28%, signal=46%</td></tr><tr><td class='lessen'>345</td><td>SMID_BREAST_CANCER_RELAPSE_IN_LUNG_DN</td><td></td><td>29</td><td>-0.23</td><td>-0.81</td><td>0.748</td><td>0.847</td><td>1.000</td><td>1869</td><td>tags=14%, list=7%, signal=15%</td></tr><tr><td class='lessen'>346</td><td>GUTIERREZ_CHRONIC_LYMPHOCYTIC_LEUKEMIA_DN</td><td></td><td>56</td><td>-0.22</td><td>-0.81</td><td>0.685</td><td>0.847</td><td>1.000</td><td>7278</td><td>tags=29%, list=26%, signal=38%</td></tr><tr><td class='lessen'>347</td><td>NIKOLSKY_BREAST_CANCER_16Q24_AMPLICON</td><td></td><td>51</td><td>-0.21</td><td>-0.81</td><td>0.745</td><td>0.847</td><td>1.000</td><td>5594</td><td>tags=20%, list=20%, signal=24%</td></tr><tr><td class='lessen'>348</td><td>MILI_PSEUDOPODIA_CHEMOTAXIS_UP</td><td></td><td>84</td><td>-0.20</td><td>-0.80</td><td>0.698</td><td>0.851</td><td>1.000</td><td>7333</td><td>tags=26%, list=26%, signal=35%</td></tr><tr><td class='lessen'>349</td><td>CHANGOLKAR_H2AFY_TARGETS_UP</td><td></td><td>46</td><td>-0.19</td><td>-0.80</td><td>0.782</td><td>0.851</td><td>1.000</td><td>5652</td><td>tags=22%, list=20%, signal=27%</td></tr><tr><td class='lessen'>350</td><td>GALE_APL_WITH_FLT3_MUTATED_UP</td><td></td><td>59</td><td>-0.19</td><td>-0.79</td><td>0.736</td><td>0.863</td><td>1.000</td><td>3704</td><td>tags=15%, list=13%, signal=18%</td></tr><tr><td class='lessen'>351</td><td>BOYLAN_MULTIPLE_MYELOMA_PCA3_UP</td><td></td><td>78</td><td>-0.18</td><td>-0.79</td><td>0.840</td><td>0.865</td><td>1.000</td><td>6274</td><td>tags=24%, list=22%, signal=31%</td></tr><tr><td class='lessen'>352</td><td>ASTON_MAJOR_DEPRESSIVE_DISORDER_UP</td><td></td><td>48</td><td>-0.19</td><td>-0.79</td><td>0.823</td><td>0.869</td><td>1.000</td><td>7735</td><td>tags=31%, list=27%, signal=43%</td></tr><tr><td class='lessen'>353</td><td>LE_NEURONAL_DIFFERENTIATION_UP</td><td></td><td>17</td><td>-0.25</td><td>-0.79</td><td>0.742</td><td>0.867</td><td>1.000</td><td>8162</td><td>tags=47%, list=29%, signal=66%</td></tr><tr><td class='lessen'>354</td><td>GRATIAS_RETINOBLASTOMA_16Q24</td><td></td><td>18</td><td>-0.22</td><td>-0.79</td><td>0.729</td><td>0.864</td><td>1.000</td><td>5594</td><td>tags=22%, list=20%, signal=28%</td></tr><tr><td class='lessen'>355</td><td>LEE_TARGETS_OF_PTCH1_AND_SUFU_DN</td><td></td><td>82</td><td>-0.17</td><td>-0.78</td><td>0.903</td><td>0.866</td><td>1.000</td><td>9241</td><td>tags=37%, list=33%, signal=54%</td></tr><tr><td class='lessen'>356</td><td>WINTER_HYPOXIA_DN</td><td></td><td>52</td><td>-0.20</td><td>-0.78</td><td>0.700</td><td>0.869</td><td>1.000</td><td>9108</td><td>tags=38%, list=32%, signal=57%</td></tr><tr><td class='lessen'>357</td><td>BILANGES_SERUM_SENSITIVE_VIA_TSC2</td><td></td><td>30</td><td>-0.23</td><td>-0.78</td><td>0.793</td><td>0.869</td><td>1.000</td><td>10163</td><td>tags=47%, list=36%, signal=73%</td></tr><tr><td class='lessen'>358</td><td>MCCLUNG_DELTA_FOSB_TARGETS_2WK</td><td></td><td>46</td><td>-0.21</td><td>-0.77</td><td>0.871</td><td>0.871</td><td>1.000</td><td>6274</td><td>tags=30%, list=22%, signal=39%</td></tr><tr><td class='lessen'>359</td><td>TAKADA_GASTRIC_CANCER_COPY_NUMBER_DN</td><td></td><td>26</td><td>-0.21</td><td>-0.77</td><td>0.800</td><td>0.870</td><td>1.000</td><td>11203</td><td>tags=58%, list=39%, signal=95%</td></tr><tr><td class='lessen'>360</td><td>CHIBA_RESPONSE_TO_TSA_DN</td><td></td><td>21</td><td>-0.23</td><td>-0.75</td><td>0.786</td><td>0.902</td><td>1.000</td><td>7519</td><td>tags=29%, list=26%, signal=39%</td></tr><tr><td class='lessen'>361</td><td>FLORIO_HUMAN_NEOCORTEX</td><td></td><td>41</td><td>-0.22</td><td>-0.75</td><td>0.858</td><td>0.905</td><td>1.000</td><td>11384</td><td>tags=51%, list=40%, signal=85%</td></tr><tr><td class='lessen'>362</td><td>SENGUPTA_EBNA1_ANTICORRELATED</td><td></td><td>154</td><td>-0.19</td><td>-0.75</td><td>0.702</td><td>0.903</td><td>1.000</td><td>7708</td><td>tags=32%, list=27%, signal=43%</td></tr><tr><td class='lessen'>363</td><td>BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE</td><td></td><td>55</td><td>-0.19</td><td>-0.74</td><td>0.884</td><td>0.907</td><td>1.000</td><td>5051</td><td>tags=20%, list=18%, signal=24%</td></tr><tr><td class='lessen'>364</td><td>VALK_AML_CLUSTER_10</td><td></td><td>33</td><td>-0.23</td><td>-0.74</td><td>0.809</td><td>0.906</td><td>1.000</td><td>3266</td><td>tags=21%, list=12%, signal=24%</td></tr><tr><td class='lessen'>365</td><td>CHIARETTI_ACUTE_LYMPHOBLASTIC_LEUKEMIA_ZAP70</td><td></td><td>67</td><td>-0.19</td><td>-0.74</td><td>0.720</td><td>0.905</td><td>1.000</td><td>4200</td><td>tags=18%, list=15%, signal=21%</td></tr><tr><td class='lessen'>366</td><td>IWANAGA_E2F1_TARGETS_INDUCED_BY_SERUM</td><td></td><td>24</td><td>-0.22</td><td>-0.74</td><td>0.821</td><td>0.904</td><td>1.000</td><td>6282</td><td>tags=25%, list=22%, signal=32%</td></tr><tr><td class='lessen'>367</td><td>FARMER_BREAST_CANCER_CLUSTER_7</td><td></td><td>18</td><td>-0.23</td><td>-0.74</td><td>0.845</td><td>0.904</td><td>1.000</td><td>90</td><td>tags=6%, list=0%, signal=6%</td></tr><tr><td class='lessen'>368</td><td>WU_HBX_TARGETS_1_DN</td><td></td><td>23</td><td>-0.23</td><td>-0.73</td><td>0.787</td><td>0.906</td><td>1.000</td><td>5478</td><td>tags=22%, list=19%, signal=27%</td></tr><tr><td class='lessen'>369</td><td>FERREIRA_EWINGS_SARCOMA_UNSTABLE_VS_STABLE_UP</td><td></td><td>155</td><td>-0.16</td><td>-0.73</td><td>0.831</td><td>0.906</td><td>1.000</td><td>5929</td><td>tags=22%, list=21%, signal=28%</td></tr><tr><td class='lessen'>370</td><td>CHO_NR4A1_TARGETS</td><td></td><td>28</td><td>-0.21</td><td>-0.73</td><td>0.805</td><td>0.907</td><td>1.000</td><td>4507</td><td>tags=25%, list=16%, signal=30%</td></tr><tr><td class='lessen'>371</td><td>SEAVEY_EPITHELIOID_HEMANGIOENDOTHELIOMA</td><td></td><td>86</td><td>-0.17</td><td>-0.72</td><td>0.926</td><td>0.913</td><td>1.000</td><td>6604</td><td>tags=22%, list=23%, signal=29%</td></tr><tr><td class='lessen'>372</td><td>KAMMINGA_EZH2_TARGETS</td><td></td><td>41</td><td>-0.23</td><td>-0.71</td><td>0.788</td><td>0.921</td><td>1.000</td><td>2334</td><td>tags=15%, list=8%, signal=16%</td></tr><tr><td class='lessen'>373</td><td>STEARMAN_LUNG_CANCER_EARLY_VS_LATE_UP</td><td></td><td>126</td><td>-0.16</td><td>-0.71</td><td>0.814</td><td>0.920</td><td>1.000</td><td>8187</td><td>tags=31%, list=29%, signal=43%</td></tr><tr><td class='lessen'>374</td><td>RICKMAN_HEAD_AND_NECK_CANCER_B</td><td></td><td>39</td><td>-0.20</td><td>-0.71</td><td>0.868</td><td>0.920</td><td>1.000</td><td>5608</td><td>tags=18%, list=20%, signal=22%</td></tr><tr><td class='lessen'>375</td><td>JACKSON_DNMT1_TARGETS_DN</td><td></td><td>19</td><td>-0.20</td><td>-0.71</td><td>0.902</td><td>0.921</td><td>1.000</td><td>3192</td><td>tags=16%, list=11%, signal=18%</td></tr><tr><td class='lessen'>376</td><td>KIM_ALL_DISORDERS_OLIGODENDROCYTE_NUMBER_CORR_DN</td><td></td><td>30</td><td>-0.19</td><td>-0.69</td><td>0.898</td><td>0.931</td><td>1.000</td><td>5246</td><td>tags=20%, list=18%, signal=25%</td></tr><tr><td class='lessen'>377</td><td>DAVICIONI_PAX_FOXO1_SIGNATURE_IN_ARMS_UP</td><td></td><td>57</td><td>-0.18</td><td>-0.69</td><td>0.908</td><td>0.934</td><td>1.000</td><td>2440</td><td>tags=12%, list=9%, signal=13%</td></tr><tr><td class='lessen'>378</td><td>GINESTIER_BREAST_CANCER_20Q13_AMPLIFICATION_DN</td><td></td><td>182</td><td>-0.18</td><td>-0.69</td><td>0.752</td><td>0.933</td><td>1.000</td><td>6845</td><td>tags=26%, list=24%, signal=35%</td></tr><tr><td class='lessen'>379</td><td>NAGY_TFTC_COMPONENTS_HUMAN</td><td></td><td>18</td><td>-0.21</td><td>-0.68</td><td>0.857</td><td>0.937</td><td>1.000</td><td>9750</td><td>tags=39%, list=34%, signal=59%</td></tr><tr><td class='lessen'>380</td><td>STONER_ESOPHAGEAL_CARCINOGENESIS_UP</td><td></td><td>36</td><td>-0.21</td><td>-0.67</td><td>0.816</td><td>0.942</td><td>1.000</td><td>4728</td><td>tags=19%, list=17%, signal=23%</td></tr><tr><td class='lessen'>381</td><td>GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_CYAN_UP</td><td></td><td>17</td><td>-0.23</td><td>-0.67</td><td>0.817</td><td>0.939</td><td>1.000</td><td>5644</td><td>tags=24%, list=20%, signal=29%</td></tr><tr><td class='lessen'>382</td><td>HEIDENBLAD_AMPLICON_12P11_12_DN</td><td></td><td>25</td><td>-0.19</td><td>-0.67</td><td>0.900</td><td>0.940</td><td>1.000</td><td>5665</td><td>tags=24%, list=20%, signal=30%</td></tr><tr><td class='lessen'>383</td><td>DORMOY_ELAVL1_TARGETS</td><td></td><td>17</td><td>-0.24</td><td>-0.67</td><td>0.859</td><td>0.939</td><td>1.000</td><td>5804</td><td>tags=24%, list=20%, signal=30%</td></tr><tr><td class='lessen'>384</td><td>HANN_RESISTANCE_TO_BCL2_INHIBITOR_UP</td><td></td><td>32</td><td>-0.19</td><td>-0.65</td><td>0.910</td><td>0.958</td><td>1.000</td><td>8006</td><td>tags=34%, list=28%, signal=48%</td></tr><tr><td class='lessen'>385</td><td>BORCZUK_MALIGNANT_MESOTHELIOMA_DN</td><td></td><td>99</td><td>-0.16</td><td>-0.63</td><td>0.961</td><td>0.966</td><td>1.000</td><td>10885</td><td>tags=47%, list=38%, signal=77%</td></tr><tr><td class='lessen'>386</td><td>KANNAN_TP53_TARGETS_DN</td><td></td><td>22</td><td>-0.20</td><td>-0.62</td><td>0.938</td><td>0.971</td><td>1.000</td><td>5201</td><td>tags=23%, list=18%, signal=28%</td></tr><tr><td class='lessen'>387</td><td>WORSCHECH_TUMOR_EVASION_AND_TOLEROGENICITY_UP</td><td></td><td>28</td><td>-0.21</td><td>-0.62</td><td>0.883</td><td>0.971</td><td>1.000</td><td>5146</td><td>tags=21%, list=18%, signal=26%</td></tr><tr><td class='lessen'>388</td><td>TCGA_GLIOBLASTOMA_COPY_NUMBER_DN</td><td></td><td>30</td><td>-0.17</td><td>-0.62</td><td>0.907</td><td>0.969</td><td>1.000</td><td>1195</td><td>tags=7%, list=4%, signal=7%</td></tr><tr><td class='lessen'>389</td><td>IKEDA_MIR1_TARGETS_UP</td><td></td><td>54</td><td>-0.16</td><td>-0.61</td><td>0.900</td><td>0.973</td><td>1.000</td><td>8748</td><td>tags=28%, list=31%, signal=40%</td></tr><tr><td class='lessen'>390</td><td>CHOI_ATL_CHRONIC_VS_ACUTE_DN</td><td></td><td>19</td><td>-0.22</td><td>-0.61</td><td>0.877</td><td>0.971</td><td>1.000</td><td>22274</td><td>tags=100%, list=78%, signal=464%</td></tr><tr><td class='lessen'>391</td><td>WEST_ADRENOCORTICAL_CARCINOMA_VS_ADENOMA_UP</td><td></td><td>19</td><td>-0.20</td><td>-0.60</td><td>0.947</td><td>0.972</td><td>1.000</td><td>6354</td><td>tags=26%, list=22%, signal=34%</td></tr><tr><td class='lessen'>392</td><td>AZARE_NEOPLASTIC_TRANSFORMATION_BY_STAT3_DN</td><td></td><td>17</td><td>-0.20</td><td>-0.60</td><td>0.969</td><td>0.973</td><td>1.000</td><td>6423</td><td>tags=29%, list=23%, signal=38%</td></tr><tr><td class='lessen'>393</td><td>WEBER_METHYLATED_HCP_IN_SPERM_DN</td><td></td><td>25</td><td>-0.17</td><td>-0.60</td><td>0.954</td><td>0.971</td><td>1.000</td><td>9379</td><td>tags=32%, list=33%, signal=48%</td></tr><tr><td class='lessen'>394</td><td>CHIARETTI_T_ALL_RELAPSE_PROGNOSIS</td><td></td><td>19</td><td>-0.17</td><td>-0.60</td><td>0.946</td><td>0.969</td><td>1.000</td><td>2123</td><td>tags=11%, list=7%, signal=11%</td></tr><tr><td class='lessen'>395</td><td>LIEN_BREAST_CARCINOMA_METAPLASTIC</td><td></td><td>30</td><td>-0.17</td><td>-0.59</td><td>0.976</td><td>0.970</td><td>1.000</td><td>8885</td><td>tags=37%, list=31%, signal=53%</td></tr><tr><td class='lessen'>396</td><td>LIN_MELANOMA_COPY_NUMBER_DN</td><td></td><td>40</td><td>-0.15</td><td>-0.59</td><td>0.918</td><td>0.969</td><td>1.000</td><td>5288</td><td>tags=18%, list=19%, signal=21%</td></tr><tr><td class='lessen'>397</td><td>HAHTOLA_SEZARY_SYNDROM_DN</td><td></td><td>43</td><td>-0.22</td><td>-0.58</td><td>0.825</td><td>0.968</td><td>1.000</td><td>10488</td><td>tags=49%, list=37%, signal=77%</td></tr><tr><td class='lessen'>398</td><td>BILANGES_SERUM_RESPONSE_TRANSLATION</td><td></td><td>19</td><td>-0.20</td><td>-0.57</td><td>0.929</td><td>0.975</td><td>1.000</td><td>22592</td><td>tags=100%, list=80%, signal=489%</td></tr><tr><td class='lessen'>399</td><td>WANG_RECURRENT_LIVER_CANCER_UP</td><td></td><td>19</td><td>-0.16</td><td>-0.47</td><td>0.978</td><td>0.999</td><td>1.000</td><td>7316</td><td>tags=26%, list=26%, signal=35%</td></tr><tr><td class='lessen'>400</td><td>TERAO_AOX4_TARGETS_SKIN_UP</td><td></td><td>28</td><td>-0.12</td><td>-0.47</td><td>0.996</td><td>0.998</td><td>1.000</td><td>7438</td><td>tags=21%, list=26%, signal=29%</td></tr><tr><td class='lessen'>401</td><td>MODY_HIPPOCAMPUS_PRENATAL</td><td></td><td>31</td><td>-0.14</td><td>-0.45</td><td>0.981</td><td>0.998</td><td>1.000</td><td>7928</td><td>tags=26%, list=28%, signal=36%</td></tr><tr><td class='lessen'>402</td><td>EGUCHI_CELL_CYCLE_RB1_TARGETS</td><td></td><td>22</td><td>-0.13</td><td>-0.40</td><td>0.994</td><td>1.000</td><td>1.000</td><td>11324</td><td>tags=45%, list=40%, signal=76%</td></tr><tr><td class='lessen'>403</td><td>SCHLOSSER_MYC_TARGETS_AND_SERUM_RESPONSE_DN</td><td></td><td>47</td><td>-0.10</td><td>-0.36</td><td>0.998</td><td>0.999</td><td>1.000</td><td>12941</td><td>tags=49%, list=46%, signal=90%</td></tr><caption class='table'>Table: Gene sets enriched in phenotype <b>Control (9 samples)<b>&nbsp<a href='gsea_report_for_Control_1717456977994.tsv'>[plain text format]</a></caption></table></div><br></body></html>